HOW MUCH ANXIETY
"There is a common tendency in our day, both
on the part of professional psychologists and laymen,
to look upon anxiety as a negative, destructive,
"abnormal" experience, one which must be fought
and if possible annihilated .... "
0 . H. Mowrer 1
Since 1950 the literature on anxiety, both
professional and lay, has increased a thousandfold in
the form of articles, symposia, reports and scientific
exhibits. And virtually all of this output reflects a
common presumptioq-that anxiety is a negative,
nonproductive experience. This viewpoint leads naturally to a discussion of how to combat or eliminate
anxiety.
But anxiety, as Mowrer implies, has its uses.
It can play a positive and constructive role in human
development. Without it neither an individual nor a
society can grow.

Productive vs.
nonproductive anxiety:
a matter of degree
For the physician the difference is not an
academic one. He must distinguish between productive and nonproductive anxiety. And the difference
is often one of degree.
In low levels of anxiety, for example, the individual is alert and sensitive to threats and acquires
an increased ability to cope. Performance is often
improved. 2
But at higher levels of anxiety the opposite is
true.2 The ability to distinguish between the dangerous and the trivial is reduced and often leads to
inappropriate behavior. Apprehension becomes fear .
And coping becomes difficult, if not impossible.

Crossing the
anxiety threshold
The key question for the physician then becomes: Is the degree of anxiety experienced produc-

tive or nonproductive for the individual patient?
And while some patients may require relatively large
amounts of anxiety to perform optimally, for others
lower levels of anxiety may prove unproductive.

Librium®(chlordiazepoxide
HCI): to help lower
the level of anxiety
When anxiety has reached levels that seriously

IS PRODUCTIVE?
impair performance, reassurance and counseling
may be sufficient for the patient. If not, adjunctive
antianxiety medication may be called for.
Librium {chlordiazepoxide HCl), by quickly
and effectively calming the anxious patient, helps to
lower the level of anxiety. When anxiety has been
reduced to manageable levels, therapy with Librium
should be discontinued.

Librium®(chlordiazepoxide
HCl):an
uncomplicated clinical course
To be truly effective, antianxiety medication
must allay anxiety without complicating the clinical
course. Librium meets this criterion. Librium, when
used in proper dosage, rarely interferes with mental
acuity. Side effects are seldom encountered. And
Librium is used concomitantly with many primary
medications.
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effects, precautioris and warnings, please consult the
brief summary of product information on this page.
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108 ff. 2. Basowitz H et al: Anxiety and Stress. New York, McGrawHill, 1955, pp. 12 ff.
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INTRODUCTION
In this issue, the MCV Quarterly continues to
publish selected papers presented at the recent
Postgraduate Course in Nuclear Medicine sponsored
by the Department of Radiology of the Medical College of Virginia. The papers reflect modern in vitro
and in vivo radioactive isotope applications. Once
again the authors deserve our thanks for their
enlightening contributions.
KLAUS RANNIGER, M.D.
Professor and Chairman
Department of Radiology
Medical College of Virginia
Virginia Commonwealth University
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Scintiphotography
Transplants

lll

Evaluation of Renal

HALCOTT T. HADEN, M.D.

Associate Professor of Radiology and Medicine, Chief. Nuclear Medicine Section, McGuire VA Hospital, Richmond. Virginia

Renal -transplantation has progressed from the
research stage to become a standard clinical
procedure. Although still generally limited to large
medical centers, renal transplants are regularly done
in over 135 hospitals in the United States. In 1972,
approximately 2,600 renal transplants were recorded
in the United States by the Renal Transplant Registry (1 ). Approximately 65% of these were cadaver
donors and 35% living donors.
The kidney transplant recipient is subject to a
variety of complications, especially during the early
post-transplant period. Radionuclide scintiphotography has been found to be a valuable method for
evaluation of renal transplant function and for
detection of some of the more frequent complications (2,3,4,5). Because of this, scintiphotography
now has a major role in transplant evaluation. This
paper will review the radionuclide procedures available and their current use in evaluation of renal
transplants.
Scintigraphic Procedures. The transplanted kidney is routinely placed in the iliac fossa. This location allows the kidney, ureter, and bladder to be
included in the field of view of a standard scintillation camera. The procedures currently in use are:
I. kidney and bladder scintigraphy using 131 1orthoiodohippurate.
2. scintigraphy of blood flow distribution followed by kidney and bladder imaging using
99mTc-Sn-DTPA.
3. scintigraphy using 99mTc-sulfur colloid.
Presented by Dr. Haden a t the Postgraduate Course in
Nuclear Medicine, February 27, 1975, in Williamsburg, Virginia.
MCV QUARTERLY 11(3): 101-107, 1975

4. scintigraphy combined with transplant
renogram or other function studies.
Jodine-131-hippurate scintigraphy. Scintiphotographs of the kidney and bladder area are obtained
approximately every 4 minutes for 20 to 30 minutes.
If the bladder is filled, the patient then voids or the
catheter is undamped and a post-voiding picture is
obtained. In a normal study there should be uniform
maximum concentration in the renal parenchyma at 4
minutes with excretion into the bladder at 8 minutes
and decreasing renal concentration by 20 minutes.
Figure I shows an example of a normal study.
Perfusion sequence and scintigraphy with 99mTcSn-DTPA . This tracer is excreted exclusively by
glomerular filtration and is not as rapidly Cleared
from plasma as is hippurate. Sufficient radioactivity
can be given to visualize the major vessels and renal
perfusion if rapid sequential scintiphotos are obtained immediately after a bolus injection. A normal
study of this type is seen in Figure 2. If renal function
is good, there will be rapid excretion of the tracer and
subsequent scintiphotos will show the kidney and
urinary tract as seen in Figure 3. If renal function is
moderately impaired, however, excretion becomes
markedly delayed and may not be adequate for
visualization. Hippurate may still give adequate
visualization in this case, so that hippurate remains
the most dependable tracer for routine use, even
though Tc-Sn-DTPA may in some cases give better
visualization.
Scintigraphy with 99mTc-sulfur colloid. Colloidal
tracers are not normally concentrated in the kidney.
However, when the changes of chronic rejection
develop, colloidal tracers are localized to some extent

IOI
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Fig I-Normal scintiphotographic transplant study using '"1hippurate. Kidney is seen in first picture and ureter and bladder are
visualized in later pictures. Time periods are indicated.

Fig 2-Scintiphotos from a transplant perfusion study using
••mTc-Sn-DTPA. Terminal aorta, iliac arteries, and transplanted
kidney are seen.

in the kidney and can be demonstrated on scintiphotography. One technique is to use a diverging
collimator so as to include the bony pelvis but exclude the liver image (6). The concentration in the
kidney is then compared with that in the bones. An
example of this study in two separate patients is
shown in Figure 4. Both patients had mild to
moderate chronic rejection but well-preserved renal
function . We have not found this study to be very
useful since it does not dependably detect acute rejection and almost all of the transplants eventually
develop some degree of chronic rejection.
Scintigraphy combined with renogram or other
function studies. Scintigraphy with 131 1-hippurate
provides only a crude and semiquantitative measure

of renal function. A transplant renogram can be obtained simultaneously and gives an additional
method of comparing serial studies but is cumbersome to obtain with standard equipment. If the intravenous dose is precisely measured and subsequent
blood and urine collection are made, the effective
renal plasma flow may be calculated. The value of
these additional measurements is not established and
they are not routinely used.
Disorders of Transplant Function. The main
criterion for satisfactory transplant function is an
adequate urine output. Serious complications are
usually manifested by a decrease in urine output.

Fig 3- Normal scintigraphic transplant study of excretion phase
using ••mTc-Sn-DTPA. Kidney, ureter, and bladder are clearly
seen.

Fig 4- Scintiphotographs of transplanted kidney after I. V. injection of ••mTc-sulfur colloid. Two separate patients. On the left,
concentration is seen in the lumbar spine, pelvis, and in the kidney
in the right iliac fossa . On the right, the kidney concentration is so
much greater than the bones that pelvis, spine, and upper femur
are only very faintly seen.
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Table I gives a list of the common causes of acute
oliguria in transplant recipients. When oliguria occurs, the cause must be promptly determined as a
guide to effective treatment.
Acute tubular necrosis is the most common
cause of acute oliguria following soon after
transplantation, especially with cadaver transplants,
and is completely reversible with adequate treatment.
If associated with the transplant procedure, this complication occurs within the first 48 hours after surgery. Acute rejection, obstructing clots, and ureteral
leaks are also common. Arterial and venous occlusion are uncommon, and we have not yet had cortical
necrosis occur. Lymphocele is a collection of lymph
adjacent to the transplanted kidney which may occur
following interruption of lymphatics in that area.
Lymphoceles usually cause compression or displacement of the ureter and bladder and may produce
urinary obstruction. They do not occur until after the
first week and may not develop until six to eight
months after transplantation.
Diagnostic Studies for Acute Oliguria. The
various causes of oliguria listed in Table I cannot be
differentiated on a clinical basis. Prompt diagnosis is
obviously of critical importance since the treatment
for each cause is different and may entail additional
risk. The order of diagnostic studies used by M. J. V.
Smith, MD, of the Medical College of Virginia
Urology Division is given in Table 2 (7) (oral communication, February, 1975).
The first item on this list, the one-hour biopsy,
refers to a kidney biopsy obtained at the end of the

TABLE I
Causes of Acute Oliguria in Renal Transplant

TABLE 2
Acute Oliguria in Renal Transplant
Order of Diagnostic Studies
I.
2.
3.
4.
5.
6.

7.

one-hour biopsy
irrigate catheter
KUB x-ray
scintigram
cystogram
cystoscopy
a. bulb retrograde
b. catheter retrograde
arteriography

transplant procedure. This may show early evidence
of acute rejection. The first four steps on this list are
without risk and often give sufficient diagnostic information to determine treatment. The subsequent
procedures should be performed only if necessary
because of added risk, especially since these patients
all receive aggressive immunosuppressive therapy.
Scintigraphic Findings in Transplant Disorders. A
brief tabulation of the scintigraphic findings in
transplant disorders is given in Table 3.
A cute tubular necrosis. With acute tubular
necrosis the kidney will still concentrate hippurate in
the renal parenchyma, although the concentration is
somewhat decreased and maximum concentration is
delayed. Typically, no excretion into renal pelvis or
TABLE 3
Scintiphotography of Renal Transplants
Using 131 l-Orthoiodohippurate
Normal
Uniform maximum concentration in renal
parenchyma at 4 minutes
Excretion into bladder by 8 minutes
Decreasing renal concentration by 20 minutes

Vascular
Arterial thrombosis
Venous thrombosis

Acute Tubular Necrosis
Delayed concentration
No excretion

Parenchymal
Acute tubular necrosis
Acute rejection
Cortical necrosis

Acute Rejection
Delayed concentration
Irregular concentration
Delayed excretion

Ureter
Clots
Leaks
Edema at anastomosis
Necrosis and retraction

Acute Tubular Necrosis with Added Rejection
Delayed irregular concentration compared
with baseline
U reteral Obstruction
Retention of tracer proximal to obstruction

Bladder
Leaks or perforations

Ureteral Leak
Tracer outside urina ry tract

General
Lymphocele

Vascular Occlusion- Arterial
No activity in kidney
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Fig 5-Selected scintigraphs obtained in a patient with two
transplanted kidneys studied with 131 1-hippurate. Both kidneys are
seen. The kidney on the patient's right (observer's left) was
transplanted 15 months previously and is the site of severe chronic
rejection. The other kidney was inserted one day previously and is
not functioning because of acute tubular necrosis.

bladder is visualized. Figure 5 shows pictures selected
from a series of scintigraphs obtained because of
severe oliguria one day after transplantation of a second kidney into the left iliac fossa. The first kidney
was inserted 15 months previously on the right side
and had developed severe chronic rejection. The rejected kidney is visualized on the patient's right
(observer's left) as an area of poor concentration suggesting a small kidney. The new transplant is well
visualized on the patient's left (observer's right), but
maximum concentration is definitely delayed and no
excretion from the kidney is seen even after 30
minutes. Within a week there was good function ·of
the new kidney.
Rejection. Rejection may be of varying acuteness
and severity. Hyperacute rejection occurs immediately after transplantation and is associated with
severe acute inflammatory and vascular changes in
the kidney. Thrombosis of small vessels occurs, and
on scintigraphic study the findings may be the same
as in arterial occlusion. The transplanted kidney must
always be removed following hyperacute rejection.
Rejection of less severity may occur at any time following transplantation. This reaction may develop
quite abruptly and may cause sudden oliguria. On
scintigraphic study, acute rejection produces delayed
and sometimes irregular concentration of hippurate.
Excretion is also delayed or may be absent. Figures 6
and 7 show scintigraphic studies of a patient who
received a transplant on 5 December, 1974. The scin-
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Fig 6-Transplant scintigraphic study four days post-transplant
with good function.

tigraphic study on 9 December, 1974, (Fig 6) shows
that the kidney is working quite well. On 11
December, 1974, the patient developed sudden
oliguria, and a repeat study on that day is shown in
Figure 7. Concentration is delayed and there is no excretion. These findings are compatible with either
acute tubular necrosis or acute rejection. However,
the time after transplantation and the demonstration
of good function two days previously exclude acute
tubular necrosis resulting from the transplant
procedure as a cause of the acute oliguria. This
patient was treated for acute rejection with resulting
improvement.
Chronic rejection is associated with delayed concentration and delayed excretion as shown in Figure
8. These findings are not specific for chronic rejection
since they may occur with other chronic parenchymal
disease of the kidney. Concentration of colloidal par-

Fig 7-Same patient as Fig. 6 two days later. Acute rejection.
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Fig 8-Sulfur colloid and hippurate scintigraphs in chronic rejection.

Fig 9-Partial ureteral obstruction producing retention in pelvis
and upper ureter, delayed visualization of bladder.

tides can be demonstrated in chronic rejection, but
this has not been particularly helpful since essentially
all of the transplants develop some degree of chronic
rejection .
Rejection may be of varying degree and may occur in combination with acute tubular necrosis or
other disorders. This may be quite difficult to detect.
However, any deterioration of renal function on scintigraphic study after the first 24 hours usually indicates rejection. It is, therefore, good practice to obtain an initial scintigraphic study at 24 to 48 hours
after transplantation as a baseline for subsequent
studies. Changes due to acute tubular necrosis will be
maximal at 24 hours.
Ureteral obstruction. The ureter may be
obstructed early by clots or later by stones or by compressing lesions such as lymphoceles. As long as renal
parenchymal function remains good there will be
good concentration of hippurate by the kidney. Scintigraphic study shows accumulation of tracer proximal to the obstruction with delayed or absent excretion into the bladder. An example of partial obstruction of the upper ureter is shown in Figure 9.
Ureteral leaks. Extravasation of urine from the
ureter or from the ureterovesical junction is a common and serious complication of renal transplantation. It has occurred in 8% to 30% of several series
with a mortality rate of 25% to 50%. Ureteral leak is
readily demonstrable by scintigraphic study, but one
must be careful to follow the study long enough to
fully evaluate any unusual appearance. It is also wise
to obtain post-voiding films to clearly establish bladder location. Figure 10 shows several pictures from a
study obtained one month after transplantation. The

patient had increasing serum creatinine, but no local
signs and was thought to have mild rejection. An abnormal collection is seen adjacent to the bladder in
the early pictures, and at 25 minutes there is a wide
area of abnormal concentration extending along the
path of the ureter. The picture at two hours shows the
radioactivity located in extravasated urine collected
around the bladder, ureter, and lower pole of the
kidney. The IO-minute picture also shows some retention of tracer in the renal pelvis and collecting system
suggesting mild partial obstruction associated with
the urinoma.
Vascular occlusion. With arterial occlusion the
kidney is not perfused and no tracer is concentrated
in the kidney. Using 99mTc-pertechnetate or DTPA,
the major vessels can be visualized and the lack of
perfusion can be demonstrated as shown in the top

Fig IO-Progressive urine extravasation from ureterovesical junction.
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half of Figure 11. When hippurate is the tracer, scintiphotos over the kidney simply show no concentration in the renal parenchyma as at the bottom of
Figure 11. These findings may occur in primary
arterial occlusion or in hyperacute rejection with
thrombosis of small vessels. In either case, surgery is
required for removal of the kidney unless a vascular
occlusion can be repaired. Venous occlusion, if complete, will block vascular perfusion and is usually followed by thrombosis in the arterial supply. However,
venous thrombosis may partially block vascular fl.ow
and the kidney may survive after a period of
decreased function. If there is viable and perfused
renal tissue still present then there should be some
concentration of hippurate. It is generally felt,
though not completely proven, that the absence of
any demonstrable concentration of hippurate indicates that the kidney is no longer viable and should
be removed.
Management of Transplant Oliguria Based on
Scintigraphic Findings. When oliguria develops in the
transplant recipient, the results of the scintigraphic
study together with clinical findings will usually indicate the management to be followed. This is briefly
summarized in Table 4. If the oliguria develops
within the first 48 hours and the scintigram shows a
clear renal image with decreased excretion, management for acute tubular necrosis is indicated. If the
time period is not compatible with acute tubular
necrosis or if subsequent scintigrams show further
deterioration, then rejection has developed. If there is
no renal image with hippurate or technetium, then

Fig I I- Arterial occlusion . U pper pictures with "mTcpertechnetate show terminal aorta and iliac arteries with " cold"
area over kidney. Lower pictures made with 131 1-hippurate show no
concentration in kidney.
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TABLE 4
H ippurate Scintiphotography in Management of
Acute Oliguria in Renal Transplants
I.

Clear renal image with decreased excretion:
Conservative Management
A. If image deteriorates on subsequent study:
Treat Rejection

2.

No renal image:
Study with Pertechnetate Bolus
A. If no perfusion:
Arteriogram or Surgery

3.

Ureteral obstruction:
Retrograde or J.V. Urogram or Surgery

4. Extravasation:
Retrograde Urogram or Surgery

surgery is required. An arteriogram can be done if it
is necessary to differentiate between hyperacute rejection and arterial occlusion. U reteral obstruction will
usually be evident on the scintigraph, but further
diagnostic procedures will be required to determine
the cause. Extravasation will also be evident on the
scintigraph, but further studies will be required to
localize the precise site and extent. In some cases, extravasation can be treated without surgery if infection
does not develop.
Conclusions.
I. Scintiphotography of the kidney and bladder
using 131 1-hippurate is the basic procedure for
transplant evaluation. This is a dependable
method for determining transplant viability
and function. It is also a dependable method
for detecting ureteral leak or obstruction,
provided that renal function is adequate.
2. Concentration of hippurate indicates that the
kidney has a blood supply, is viable, and has
recoverable function. Absence of hippurate
concentration indicates severe and probably
irreversible kidney damage.
3. Scintiphotography with 99 mTc-Sn-DTPA
gives good resolution in normally functioning
kidneys. With severely impaired renal function, this tracer is inferior to 131 I-hippurate.
4. Rapid sequence scintigraphy of the initial circulation using technetium tracers can
visualize major vessels . and renal perfusion.
Quantitation and comparison between
studies are difficult.
5. A single scintiphotographic study will not
differentiate between acute tubular necrosis
and rejection. Serial scintiphotographic
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studies may indicate rejection if deterioration
of function is shown to occur later than 24
hours after transplantation.
6. Colloidal tracers may concentrate in the
kidney in chronic rejectjon. This phenomenon has not yet been clinically helpful.
7. The scintigraphic findings in transplant disorders have been reviewed and a schema for
management based on these findings has been
presented.
Figures l and 3 are reprinted from the Journal of Nuclear
Medicine, Vol. 16, No. 7, with permission of publisher.
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Use of Bone Scanning and Skeletal Radiography
in the Diagnosis of Bone Metastasis
JAY C. MALL, M .D. AND PAUL B. HOFFER, M .D .

Department of Radiology, University of California Medical Center, San Francisco, California

The radionuclide bone scan is becoming increasingly useful for evaluating a wide variety of bone
and joint disorders. However, the commonest application is still the detection of skeletal metastases in
the patient with known or suspected neoplastic disease. The role of this examination relative to other
well established methods of evaluating these patients,
especially the radiographic skeletal survey, is not
clear to all physicians. We hope in this communication to define the role of the radionuclide bone scan
and to place in perspective the integral relationship
between the "scan" and the "survey," the two
radiologic modalities which today are the principal
methods of evaluating the skeletal system for
metastatic disease.
Radiopharmaceuticals. Historically, numerous
agents have been used for bone scanning, but only a
small number have been applicable for general
clinical use. The first of these were the strontium
isotopes, strontium-85 and strontium-87m. Subsequently, fiuorine- 18 and, most recently, the
technetium-99m-labeled phosphate compounds have
been used .
Strontium. Strontium is an analogue of calcium
and, as such, is incorporated into the hydroxyapatite
crystal by an ion-exchange process with calcium (I).
Unfortunately, the plasma clearance of strontium is
slow due to partial binding with plasma proteins (2,
3). Excretion occurs by both urinary tract and bowel
(4).
Strontium-85 nitrate was one of the first agents
used for imaging of bone lesions. Its long physical
Presented by Dr. Hoffer at the Postgraduate Course in
N uclear Medicine, February 27, 1975, Williamsburg, Virginia.
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half-life of 65 days severely limited the administered
dose, which was usually 100 microcuries. The presence of bowel activity in the first few days following injection necessitated cleansing enemas and/ or
long delays between isotope administration and scan.
Its 514 kev photon was also much higher than ideal
for nuclear imaging instrumentation. Nevertheless,
85 Sr was a clinically useful bone scanning agent.
Strontium-87m has a considerably shorter physical half-life (2.8 hours) and lower photon energy (388
kev) making it a physically more desirable agent.
Unfortunately, the high body-background during the
first 12 hours following injection results in less than
optimal clinical images (2) and, therefore, this agent
has not been widely used for bone imaging.
Fluorine-18. Fluorine-18 is a hydroxyl analogue
which is incorporated into bone by an ion-exchange
process forming a fiuorapatite crystal (I, 5). Bone has
a very high affinity for fluorine with most of the
radionuclide extracted from the blood on the initial
transit (2, 5). The renal extraction efficiency is also
high and, therefore, plasma clearance of 18 F is the
most rapid of any of the clinically useful bone scanning radionuclides (6,7). Excellent bone-to-background . ratios can be obtained with 18 F at 1 to 2
hours following intravenous injection (3, 6). The halflife is very short ( 1.8 hours) which is advantageous
from the standpoint of patient dose. However, the
short half-life of 18 F is also a problem because it is
cyclotron-produced (8) and, therefore, its use is
limited to those locations in close proximity to a
cyclotron . The 511 kev annihilation radiation from
18 F makes imaging with the gamma camera difficult.
The best images are obtained with a rectilinear scanner or special positron camera (5, 9). Transportation
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problems and cost, both related to the short half-life
of 18 F, have inhibited its clinical use.
Technetium-99m-labeled compounds. This group
of compounds contains the phosphate polymers,
pyrophosphate and polyphosphate, and their organic
analogues, the diphosphonates. These agents localize
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in bone crystal by surface chemisorption rather than
ionic exchange ( l 0, 11 ). The terminal phosphate
groups of the 99mTc-labeled compound react with the
"phosphate gaps" which are present in the imperfect
bone crystals. (The 99mTc acts only as a label unlike
18 F and the Sr isotopes). Plasma clearance varies

'

Fig I- Decreased uptake in Ilium (arrow) in patient with
metastatic bone lesion. Such "photopenic" lesions occur as a result
of lack of hyperemic response to tumor due to debilitation , failure
of tumor to provoke response, or radiation to region of lesion.

Fig 2- Diffuse increase in skeletal activity denoted by "absence"
of renal activity. In addition to diffuse metastasis, the absent
kidney sign may also be seen in severe renal disease, hyperparathyroidism and hypermetabolic states.
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TABLE I
Bone Scans vs. Skeletal Survey
for the Detection of Metastatic Lesions to Bone
Radionuclide
Source
Sr

18f1

99mTc

No. of
pts.

+ scan
-x-ray

-scan
+ x-ray

DeN ardo (l 966)
DeNardo et al. (1972)
Briggs (l 967)
Bessler ( 1968)
Harmer et al. (l 969)
Legge et al. ( 1970)
G nekow et al. ( 1972)

84

38%

4%

83
104
47
186
353

20%
15%
41 %
13%
8%

1%
1%
6%
2%
2%

Harmer et al. ( 1969)
Blau et al. (1972)
Hopkins et al. (1972)
Merrick (1973)

112
239
104
119

31 %
15%
20%
13%

3%
4.5%
4%
0

Desaulhiers (1973)
Pendergrass (1973)
Citrin et al. (1974)
Barrett and Smith (l 974)

100
259
70
90

9%
20%
10%
71 % (of
lesions)

1%
2%
0
2%

among the principal agents comprising this group
with the diphosphonates being cleared most rapidly,
pyrophosphate cleared somewhat less rapidly, and
polyphosphates being cleared least rapidly (7). The
bone-to-background ratios achieved with the
diphosphonates at 3 hours is almost comparable to

TABLE 2
Bone Scan vs. Skeletal Survey For Specific Tumor Types
+sca n
Source
Breast
Sklaroff and Charkes ( 1968)
Galasko (1969)
Galasko ( 1971)
Marty and Hoffman (1972)

-sca n

# ofpts. - x-ray + x-ray
0
0

64
100

16%
29%

164

26%

82
206

30%
7%

0

Prostate
Morgan and Mills (1968)
Williams et al (1968)
Roy et al (1971)
Shearer et al (1974)
Bisson et al (1974)

66
70
30
61
81

42%
21 %
53%
12%
27%

0
0
0
1%
1%

Lymphoma
Weber et al ( 1968)
Harbert and Ashburn ( 1968)
Mora n et al (1973)

19
51
80

74%
12%
5%

0
4%
0

Lung
Sauerbrum et al (l 972)
Shirazi et al ( 1973)

1%

that achieved with 18 F at l to 2 hours (6, 7). Other advantages of this group of agents are the short half-life
of 99mTc (6 hours) which permits the safe administration of millicurie doses and .near optimal gamma
energy (140 kev) and high photon flux which make
possible rapid performance of the procedure and
good spatial resolution with the gamma camera, the
most widely used nuclear imaging device. The ready
availability and easy preparation from commercial
kits with a long shelf-life also make them ideal for
general clinical use. The 99mTc-labeled compounds
are the current agents of choice for bone scanning.
The availability of these excellent and convenient
agents has fostered the recent widespread clinical
popularity of bone scanning.
"Scans Signs" of Tumor. Considerable laboratory data has accumulated over the past years
indicating that the two principal factors involved in
the uptake of bone-seeking radionuclides into the
bone are 1) bone blood flow and 2) metabolic activity
of the bone ( 10, 12, 13 ). Recent evidence has indicated that for 18 F and the 99 mTc-labeled phosphate
compounds, bone blood fl.ow is the most important
factor (I 0).
The detection of metastatic tumor in bone is
based on the premise that the destructive and
reparative events that occur in the bone as a result of
a metastatic deposit cause a localized increase in
blood fl.ow and bone turnover. This in turn results in
localized increased uptake of the bone scanning agent
which is imaged as a "hot spot" on the bone scan.
This "hot spot" can usually be easily recognized by
an alteration in the bilateral symmetry or, as with
the axial skeleton, an alteration of the homogeneous
uptake in the spine. A second "scan sign" of tumor
involvement is a localized area of decreased uptake of
the bone scanning agent (Fig !). This has been referred to as a "photon deficient" or "photopenic" abnormality and occurs in cases where there is replacement of a portion of bone by tumor with little or no
reparative response on the part of the host because of
the nature of the tumor or the debilitated state of the
patient (14 ). (Similar findings noted by R . S. Hattner, MD , unpublished data.) This is a distinctly less
common sign of skeletal involvement than a localized
area of increased uptake. A third "scan sign" of metastatic involvement of the skeleton is diffuse but uniform increased uptake which does not alter the bilateral symmetry and may only be recognized by the
decrease in renal activity (Fig 2) (15). Normally, the
kidneys in adult patients can be clearly identified at
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3 to 4 hours following administration of the 99mTc
compounds. The absence of renal activity is a rare
but important manifestation of metastatic skeletal involvement which occurs when so much of the radionuclide is deposited in bone that virtually none is
available to be localized in the kidney. In some reported series, this "scan sign" was unrecognized and
such cases were termed false-negative (16, 17).
Comparison of Bone Scan to Bone Survey. Many
clinical studies have been performed comparing the
relative sensitivity of the radionuclide bone scan and
the radiographic skeletal survey for the detection of
skeletal metastases. In earlier reports, 85Sr and 87 mSr
were the isotopes used for radionuclide bone scanning, but in more recent reports 18 F and 99mTc-labeled
phosphate compounds have been employed. These
studies are summarized in Table 1 (5, 18-28). All of
these studies indicate that the radionuclide bone scan
is more sensitive than the radiographic skeletal survey for detecting skeletal metastases. Some reports
indicate that the results with 99mTc-labeled phosphate
compounds are even better than with 18 F or the Sr
agents (26-31 ). For certain common neoplasms, a
particularly large experience has accrued over the
years to compare the two techniques of bone scanning and skeletal survey on a tumor-oriented basis.
These comparisons are summarized in Table 2 (3245) and as noted by E. M. Moran, MD (oral
communication, June, 1973 ).
Although it is quite clear that the radionuclide
bone scan is more sensitive than the radiographic
skeletal survey for detecting skeletal metastases, it is
important to remember that the examination is nonspecific in nature. Focal areas of increased
radionuclide uptake in bone are invariably due to
some skeletal abnormality; however, it must be noted
that the scan can be "positive" in numerous conditions other than neoplasm (Fig 3A and 38) (46, 47).
Table 3 is a list of non-neoplastic conditions which
cause focal increase in radionuclide uptake in bone.
The radiograph, on the other hand, while not as sensitive, is quite specific and may exhibit characteristic
patterns which allow for a more accurate etiologic
diagnosis. For these reasons, a radiograph is always
necessary to assess the significance of a scan abnormality.
False-negative radionuclide bone scans occur infrequently, in approximately 0.4% of patients in most
of the recent studies as noted in Tables 1 and 2. These
have been seen to occur in certain specific situations ( 17,48-50). They are: 1) Some patients with
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Fig 3A-Abnormal bone scan revealing increased radionuclide
uptake in the left clavicle and proximal right tibia.

myeloma; 2) some patients with tumor of anaplastic
cell type; 3) some severely debilitated patients with
poor host response; 4) patients with diffuse disease
uniformly involving the whole skeleton; 5) patients
with pelvic lesions obscured by a high level of activity
in the bladder; 6) lesions that have been irradiated.
As to the incidence of false-positive bone scans, in
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Fig 38-Radiograph of clavicle reveals coarsened trabecular pattern and sclerosis typical of Paget's disease.

those clinical studies in which lesions detected by
scan but not by x-ray were evaluated by follow-up xrays, biopsy, or autopsy, no actual false-positives
have occurred (20,24,39,49).
TABLE 3
Non-Neoplastic Causes of Positive Bone Scan
Traumatic
Fracture
Slipped epiphysis
Metabolic
Paget's
Renal osteodystrophy
Hypertrophic pulmonary osteoarthropathy
Gout
Rickets
Inflammatory
Arthritis (any type)
Osteomyelitis
Tendinitis
Miscellaneous
Aseptic necrosis
Osteitis pubis
Hyperostosis frontalis interna
Post-thoracotomy

The Unified Radiologic Approach. Because of the
already high and ever increasing cost of medical care,
we need to reassess the manner in which bone scans
and radiographs are utilized so that the patient may
benefit from minimum waste and duplication of
effort. To this end, we have developed a unified
radiologic approach to the detection of skeletal
metastases (51 ). An appropriate examination is
"tailored" individually for each patient according to
the scheme outlined in Figure 4 which is based on an
extensive review of the literature as noted above.
Because of the extensive experience in patients
with primary neoplasms of breast, lung, and prostate,
and also lymphoma, it is reasonable to perform the
bone scan as the primary study in these patients. It
has even been suggested that the bone scan completely replace the skeletal survey in the evaluation of
all patients for skeletal metastases (52). This may
shortly come to pass; however, reported experience
with primary neoplasms other than those mentioned
is not yet great enough. Therefore, we believe that in
those patients it is still necessary to perform both
complete examinations. It is much more efficient,
nevertheless, to perform the scan as the initial study,
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Fig 4-Scheme for radiologic examination of patients with suspected pone metastasis.

even in the latter group. This is because the
radionuclide bone scan, as generally performed, is an
evaluation of the entire skeleton whereas the
radiographic skeletal survey, as generally performed,
covers only the axial skeleton. Thus, any sites outside
the axial skeleton which may be positive on the scan
can ~e radiographed at the time the skeletal survey i~
obtamed, thereby eliminating wasted time and effort.
This approach is feasible only if false-negative , and to
a lesser extent, false-positive bone scans occur infrequently . False-negative scans occur infrequently and
Usually in specific circumstances as described above.
To further minimize this possibility, however, we
have incorporated into our approach a radiograph of
the pelvis even if the scan is normal. As explained
above, false-positive bone scans are, for practical
purposes, almost nonexistent.
The efficacy and practicability of the unified ap?roach was determined in a trial period during which
1t was applied to all patients referred to the radiology
department for either radionuclide bone scan or
radiographic skeletal survey for the detection bf
skeletal metastases . A comparison of the individually
"tailored" examination actually performed with the
examination (or examinations) requested by the
clinical service revealed malutilization of these
radiologic modalities; that is, superfluous, inadequate

or inappropriate studies were requested in almost
half the patients examined (51) .

Conclusions.
1. Technetium-99m-labeled phosphate compounds are currently the agents of choice for radionuclide bone scanning .
2. Metastatic involvement of bone is most frequently identified by a localized area of increased uptake. Uncommon signs of skeletal metastasis are a
localized area of decreased uptake and generalized
symmetrically increased uptake with reduced renal
excretion .
3. Radionuclide bone scanning is much more
sensitive than the radiographic skeletal survey for the
detection of skeletal metastases.
4. Since the findings on the bone scan are nonspecific, all abnormal areas should be radiographed
to determine the nature of the abnormality.
5. The incorporation of the radionuclide bone
scan and the radiographic skeletal survey into a single
unified examination for the detection of skeletal
metastases, formulated and coordinated by the
radiologist, is desirable, practicable, and efficacious.
Table 1 and Table 2 reprinted with permission from
Radiology, Vol. 11 7, No. I.
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Figure 4 reprinted with permission of Radiology, Vol. 11 7,
No. l.

16. FRANKEL RS, JOHNSON Kw, MABRY JJ , ET AL: "Normal"
bone radionuclide image with diffuse skeletal lymphoma.
Radiology 111:365-366, 1974.
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Trauma is now a major medical problem. Accidental injuries constitute the fourth leading cause of
death in the United States, and the primary cause of
death below the age of 37.
The costs of immediate medical and surgical
care, prolonged hospitalization, and lost productivity
amount to several billions of dollars annually.
Nuclear medicine techniques have an important
place in the evaluation of the injured patient. In
general, they are rapid and noninvasive. They can
provide functional as well as anatomic information.
The sensitivity is often greater than that of routine
radiographic procedures, particularly in the evaluation of bone lesions. The accuracy of imaging in
evaluating traumatic damage to the skull and abdominal organs approaches or equals that of
angiography.
An awareness of the wide range of examinations
available to the physician who must evaluate and
treat the injured patient is necessary if these extremely useful techniques are to be utilized.
The following discussion will describe
From the Division of Nuclear Medicine, Department of
Radiology, Albert Einstein College of Medicine, Bronx, New
York 10461 , and presented by Dr. Freeman at the Postgraduate
Course in Nuclear Medicine, February 27, 1975, Williamsburg,
Virginia.
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the radionuclide procedures used in diagnosis of
trauma and their clinical usefulness. For review of the
literature and extensive documentation of the studies
and results explained below, the reader is referred to
the articles listed at the conclusion of this discussion
(l-4). Specific citations will not be made here, except
for studies not included in these reviews.
I. Central Nervous System Trauma.
A. Brain Imaging: Radiographic examination of
the skull provides minimal information in the patient with head trauma. The presence or absence of
linear skull fracture has no demonstrable relationship
to the presence of significant intracranial damage
(5, 6). Contrast angiography is highly specific and
provides high-resolution studies of the intracranial
vascular tree and traumatic mass lesions. However,
it is expensive and uncomfortable and has a significant morbidity.
Radionuclide studies are more revealing than
plain films. They are also less expensive, less uncomfortable, and far less invasive than angiographic
procedures and can provide useful information about
intracranial blood flow and traumatic damage.
I . Extracerebral hematomas. Subdural hematomas are found in 55% to 70% of patients succumbing to head injuries. Epidural hematomas occur
about one-fifth as frequently. The patient with an
MCV QUARTERLY 11(3): 116-127, 1975
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acute collection may be too s.e riously injured to be
studied, but imaging studies can be quite useful in the
patient with a chronic subdural or, more rarely,
chronic epidural hematoma.
In subdural hematoma, caused by rupturing of
cerebral veins passing through the subdural space en
route to the venous sinuses, the blood first clots and
may liquefy in two to four days. A fibrinous
pseudomembrane forms during the next ten days, followed by development of a true fibrous membrane by
three to four weeks.
The most popular radionuclide for evaluation
of cerebral collections is 99 mTc-pertechnetate.
More recently, 9 amTc-DTPA, -glucoheptonate, -diphosphonate, and -citrate have been successfully
used and in selected cases may prove superior to
pertechnetate (7, 8, 9). It is not certain whether the
accumulation of nuclide in the subdural fluid or in
the membrane accounts for the appearance of activity
on the brain scan. Certainly, scans are more likely to
be positive late in the course, when membranes are
well-developed, than early, before they have formed.
The typical appearance of an extracerebral
hematoma is a "hot" crescent seen on anterior and
posterior static views, with little or no abnormality
on lateral view (Fig 1). The crescent appearance is not
specific, and can be seen in many intra- and extracranial lesions, including scalp trauma, skull fracture, craniotomy defect, unilateral Paget's disease,
meningitis, cerebral contusion or hematoma, infarct,
and tumor. False-positive crescents can be caused by
rotation of the head. The intracerebral location of
some of these conditions can often be determined on
lateral views, where the circumscribed nature of the
increased activity can be quite different from the
diffuse increase seen in subdural hematoma. Of
course, peripheral intracerebral lesions may be difficult to differentiate. Correlation with physical
findings, radiography, and dynamic imaging (see
below) is necessary in evaluating the crescent sign.
Another, much less common, appearance of a
subdural hematoma is the "rim sign," a curvilinear
area of increased activity adjacent to an area of
decreased activity. It is probably caused by displacement and compression of normal brain by the extracerebral collection.
The appearance of epidural hematomas is less
extensively documented because fewer patients have
been studied. The patterns appear to be the same as
those of subdural hematoma.
Extracranial lesions can often be ruled out or
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confirmed by performance of dynamic brain imaging
(Fig 1). A bolus of 10 to 15 millicuries of the
radionuclide is injected rapidly into a peripheral vein.
The Oldendorf technique of arterial occlusion may be
used, but is probably not neccessary for this purpose.
A simple tourniquet and relatively quick injection of
a high-activity, low-volume ( ~ 1 ml) bolus usually is
adequate. The patient's head is positioned under the
gamma camera before injection, usually in the
anterior position unless a posterior site of injury indicates the need for a posterior study. Images are obtained every 2 to 3 seconds for 15 to 25 seconds.
Static images in anterior, posterior, and both lateral
positions are then obtained immediately and two to
four hours later.
The diagnostic accuracy or sensitivity of the
brain scan ranges from approximately 50% during the
first ten days after trauma to 90% thereafter. The
results in children are somewhat less impressive, in

Fig I-Right subdural hematoma. The initial 2 frames on top are
from the early posterior radionuclide angiogram. Note peripheral
avascular zone superiorly (arrows) . The static views performed 2
hours later show a thickened right vascular rim on the sagittal projections associated with a diffuse increase in activity over the
hemisphere on the right lateral view. Compare this latter finding
with the normal left lateral view.
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the range of 60% to 75%. Dynamic imaging has
reportedly raised the diagnostic accuracy of early
studies to nearly 100%, but in some series has been
positive in only half of proven cases of subdural
hematoma. The sensitivity of the examination is improved by obtaining images several hours after injection and repeating equivocal studies after several
days. This also decreases the problem of falsepositives because of soft tissue scalp trauma, which
demonstrates rapidly diminishing activity over
several days.
A negative study does not rule out the presence
of a small subdural collection. The resolving
capabilities of cerebral angiography are unquestionably higher and its sensitivity approaches
100%. Radionuclide imaging should diagnose collections of more than I cm in diameter. It may be difficult to appreciate subdural collections by imaging
when they are located in the posterior fossa, under
the temporal lobe, or in other unusual locations.
Bilateral small collections may be deceptive since
the observer cannot compare one side to the other.
This is a particular problem in children, in whom
bilateral collections are more common than in adults.
However, the striking thickness of the vascular rim
can suggest the diagnosis (Fig 2). The study should
not be called truly negative unless delayed views are
obtained and are normal. The incidence of positive
scans increases over one to four hours after injection,
and equivocal studies can be definitely diagnostic if
delayed imaging is performed.

Fig 2-Bilateral subdural hematomas. This static scintiphotographic study was performed 2 hours following injection.
Thickening of both vascular rims on the sagittal projections is associated with a diffuse increase in uptake over both hemispheres on
the lateral views.

2. Intracerebral hematoma and contusion. Few
cases of intracerebral hematoma have been reported,
probably because the acute nature of the patient's
condition often precludes radionuclide evaluation.
However, the appearance of a well-defined area of increased activity within the brain, on all projections,
has been described. The appearance is indistinguishable from tumor, abscess, or infarct, and
the study must be interpreted in context and
sometimes repeated. Again, delayed imaging will lead
to more positive diagnosis. The sensitivity of the
study is about 65% to 75%.
Contusion may present a similar appearance on
imaging studies, but no definite mass can be seen
when angiography is performed. The scan returns to
normal over several weeks. More often, the scan in
cases of contusion is normal.
3. Radionuclide cisternography. This is a more
difficult and invasive procedure than brain scanning,
and because of the risk of aseptic meningitis, causes a
higher morbidity. However, in certain instances it can
reveal very useful information. A small volume containing 0.5 to 1.0 millicuries of m1n-DTPA is introduced directly into the subarachnoid space via
lumbar or cisternal puncture. Sequential views in
lateral and anterior positions over the spine and skull
are necessary.
The study can be used to detect CSF leaks from
the spinal canal (I 0) (Fig 3) or skull. In the latter
case, nasal pledgets can be left in place for later
counting as an aid in detecting leaks through the
frontal sinuses, cribriform plate, sphenoid sinus, and
petrous bone. If proper techniques are employed, the
accuracy of the procedure is quite high (>90% ). After
a leak has been seen, rectilinear scanning may be performed for more exact correlation with skull x-rays
in determining the surgical approach .
The syndrome of normal-pressure hydrocephalus can occur after traumatically induced subarachnoid bleeding. The mechanism is presumed to
be obstruction of usual CSF absorption pathways
by adhesions. Abnormal CSF flow patterns can be
detected by radionuclide cisternography. Serial imaging at I, 6, 24, and 48 hours demonstrates filling of
dilated ventricles at 24 hours without the normal activity over the hemispheres, and ventricular stasis at
48 hours.
II. Liver and Spleen Injury.
The liver is injured in 5% to 10% of patients
suffering blunt abdominal trauma, and is the most
commonly injured organ in penetrating abdominal
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defect that, on appearance alone, can be indistinguishable from tumor, abscess, cyst, or infarct.
A bipartite or accessory spleen may simulate transection, but this has not yet been a clinical problem in
our experience. Subcapsular hematoma causes a flattening of the border of the liver or spleen, and separation of the organ from the body wall or diaphragm,
but the latter is difficult to discern on radionuclide
imaging, and variations in normal organ position can
be deceptive. Patchy or inhomqgeneous uptake may
also be seen and, in the liver, .must be differentiated
from cirrhosis.

Fig 3-Spinal cerebrospinal fluid leak . The patient was a 50-yearold man who developed right lower extremity weakness following a
stab wound of the low back. Upper Left. Posterior Anger camera
scintiphoto of head 4 hours after intrathecal Cl-C2 injection of 131 lHuman Serum Albumin shows normal distribution of activity in
basal cisterns. Upper Right. Posterior view of the dorsolumbar
spine at 4 hours shows normal uniform distribution of activity.
Lower Lefi. Posterior view of head at 24 hours shows normal
progression of tracer over convexity . Lower righ1. Posterior view of
lumbosacral spine at 24 hours shows oblique band of activity (arrows) running between subarachnoid space and site of stab wound
(hot spot marked by "Co source). Band represents CSF-cutaneous
fistula.

trauma. The spleen is ruptured or lacerated twice as
often as the liver in blunt abdominal trauma. The
mortality of liver damage is higher than that of the
spleen, accounting for as many as 30% of the deaths
occurring after closed abdominal injury.
Clinical and laboratory- data are often nonspecific, as are plain films of the abdomen.
Radionuclide imaging is as reliable as angiography
(see below) and does not require arterial puncture or
injection of large doses of hyperosmotic media.
Examination is performed within a few minutes
after injection of I to 3 millicuries of 99 mTc-sulfur
colloid. Anterior, posterior, and lateral views are absolutely necessary. Oblique and angled views are
often needed for full evaluation of the spleen (see
below). Some investigators have found dynamic imaging useful, but its role is less vital than in skull,
renal, and vascular injury.
Laceration of a solid organ causes a linear or
focal defect in the visualized activity (Figs 4, 5). A
localized hematoma causes a round or wedge-shaped

Fig 4-Liver laceration and hematoma in young male adult after
motorcycle accident. A and B are anterior and right lateral ••mTcsulfur colloid liver scintiphotos, respectively , which show a large
right lobe defect. In C, selective hepatic angiography shows pooling of opaque material in a large cavity (arrows) which corresponds
to the defect seen on scan. This represents pseudoaneurysm with
hematoma formation. D and E are scintiphotos obtained 5 months
after surgical repair . The tremendous regenerative ability of
hepatic tissue is demonstrated.

120

LUTZKER AND FREEMAN: RADIONUCLIDE IMAGING EVALUATION

No false-negative results have been reported in
diagnosing hepatic injury. The incidence of falsepositive scans is quite low, on the order of 3% or less
(Table 1). Because no clinically significant injury will
apparently be missed, it is a suitable screening test for
liver damage. Angiography can be reserved for
equivocal cases or when precise anatomic definition is
necessary for surgery.
Spleen imaging has led to a correct diagnosis in
about 90% of more than 200 cases reviewed (Table 2).
In terms of clinically significant splenic damage, the
accuracy of the procedure is even higher.
lntraparenchymal extravasation or "puddling" as
seen on angiography is not a criterion for surgery if it
is the only demonstrable abnormality; such a case accounts for one of the so-called "false-negative" cases
reported. A proven subcapsular hematoma has been
missed scintigraphically, since the expected flattening
of the splenic border was not present.
Attention to positioning of the detector head
and knowledge of the relationships of the left hepatic

Fig 5-Ruptured spleen in a 9-year-old boy after trauma. A. ••mTc-sulfur colloid scintiphotos show a large spleen with a wide lucent
band through the midportion. B. Selective celiac angiogram also shows the wide defect seen in the splenogram . C. Longitudinally
cut surgical specimen confirms the rupture through the midbody of the spleen.
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TABLE 1
Liver Imaging in Abdominal Trauma

Study

A
B

c
D

No. of
Patients

True
Negative

False
Negative

True
Positive

False
Positi ve

119
19
8
16

100
16
3
15

0
0
0
0

17
3
5

2
0
0
0

98.3
100
100
100

162

134

0

26

2

98.7

lobe to the spleen can minimize the chance of falsepositive diagnosis of spleen injury. Angling and
obliquing the detector allows visual separation of the
spleen from the overlapping left hepatic lobe, which,
in the straight posterior postion, may simulate a
wedge-shaped defect in the spleen (see accompanying
article on pitfalls and artifacts in this issue). Rib impressions may also simulate lacerations, but can be
suspected by the orientation of the defect and ruled
out by obtaining views with a lead strip marker in
place over the rib.
With an unequivocally normal study, further examination of the spleen and liver is usually unnecessary. A critically ill patient with a definitely abnormal
scan requires surgery. In cases of equivocal imaging
findings or atypical history or physical examination,
angiography may be necessary for further evaluation.
This is particularly important when there is a possibility of subcapsular hematoma, which can lead to
delayed rupture. However, despite the superior
resolution of angiography, sizable lesions 'may be
missed, possibly because it is difficult to obtain multiple projections (Fig 6).
Any patient with tra~ma to the left upper
quadrant should be evaluated for possible kidney injury in addition to splenic injury.

%
Correct

III. Genitourinary Tract Injury.
Although penetrating wounds and iatrogenic
damage such as renal biopsy and surgery account for
a number of renal injuries, about 90% are the result of
blunt abdominal trauma, predominantly automobile
accidents. Severe renal injury is not so often an immediate threat to life, as is severe hepatic or splenic
injury, except in cases of penetrating injury.
However, the late sequelae of renal parenchymal loss
can be serious and include hydronephrosis, calcified
hematoma, calculi, pseudocyst, and scarring and
arterial injury leading to hypertension .
Minor renal damage occurs in the majority
(65%) of instances of renal injury, according to the
widely used classification of Hodges, et al. Contusion
is the commonest minor injury. Major disruption of
the parenchymi\, with rupture of the capsule, extension into the collecting system, and/ or segmental
vascular occlusion accounts for 30% of renal injuries.
Critical injury, with disruption of the renal hilus with
its major vessels, is rare.
Although the intravenous urogrijm, preferably
with a high dose of contrast media, is usually the first
examination performed in the patient with suspected
renal injury, studies of diagnostic quality cannot
always be obtained. A rapidly running intravenous

TABLE 2
Spleen Imaging in Abdominal Trauma

Study

A
B

c
D
E

No. of
Patients

True
Negative

False
Negative

True
Positive

Fa lse
Positive

119
19
32
16
16

91
14
19
2
9

0
0

24
II

4
0
0

I

0

12
7

0

96.6
100
93.7
87.5*
100

202

135

2

59

5

96.0

* False-positive can be avoided. False-negative was insignificant puddling. (see text).

I

%
Correct
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Fig 6-Minor nonsurgical spleen injury in 33-year-old man after stab wound. A. A ••mTc-colloid study at the time of injury (top
row) shows a foca l area of decreased uptake along the posteromedial border. Angiogram performed at this time is shown in 6B. Repeat
radionuclide study two months later (bottom row) in the same left lateral and posterior veiws show disappearance of the abnormality.
B. Selective splenic angiogram (late phase) at time of injury in anteroposterior position fails to show the abnormality seen on the
scintigraphic study. Apparent lucencies over the lower portion of the spleen represent bowel gas.

line can cause significant dilution of the contrast
media, and overlying gas and feces can interfere with
interpretation.
Radionuclide examination, in dynamic and
static modes, provides information about the
vascular supply of the kidney, parenchymal integrity,
and excretory function, combining some aspects of
both urography and angiography. For dynamic imaging, a 10 to 15 millicurie bolus of one of the 99mTclabeled renal agents is injected rapidly into a
peripheral vein, preferably the antecubital. Beginning
6 seconds after injection, 2- to 3-second exposures are
obtained until approximately 30 seconds after injection. If rapidly filtered 99mTc-Sn-DTPA is used, immediate and serial scintiphotos over a 30-minute
period are made. If one of the agents that is fixed to
the tubules is used (99mTc-iron-ascorbate, 99 mTc-glucoheptonate, or 99 mTc-DMSA), one- and two-hour
static delayed images are obtained. The 99mTclabeled compounds have largely replaced 197 Hgchlormerodrin as cortical imaging agents because of
more favorable physical characteristics.
The posterior view is used for renal imaging. A
diverging collimator is helpful for imaging large adult
patients, in order to image both kidneys
simultaneously in one field, but is not necessary in the

average adult or in children. Delayed imaging of the
bladder is done in the anterior position.
The commonest renal injury, cortical contusion,
may cause early diminished blood flow on dynamic
imaging and persistent defect or sometimes
generalized decreased activity on delayed imaging
(Fig 7). A persistent focal defect is difficult or impossible to differentiate from infarct or hematoma . Infarct will remain as a defect on follow-up imaging,
while contusion may resolve over two to four weeks
(Fig 7). Hematoma may resolve or progress to
infarct.
If no activity is seen to reach the kidney on
dynamic and subsequent static imaging, renal arterial
occlusion or other disruption of the renal hilus must
be suspected. This is an indication for immediate surgical intervention to attempt salvage of renal function. Arteriovenous fistula caused by trauma or renal
biopsy is apparent on dynamic imaging as an area of
early intense activity and rapid washout.
A fragment of lacerated or fractured kidney may
demonstrate diminished perfusion early and increased activity late, but the associated linear defect
dividing the kidney into more than one fragment
often distinguishes this pattern from contusion.
Extravasation of activity can be seen in
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Infarct
2 mos. later
Fig 7-Value of serial radionucli<;le examination in differentiating between renal contusion and
infarction. Posterior "'Hg-chlormerodrin scintigraphy following blunt trauma (lop row) shows
diminished activity in the medial portion and lower half of the right kidney. Repeat study 3
weeks later demonstrates considerable improvement in the appearance of this contused kidney.
Sequential radiochlormerodrin study in another patient with blunt trauma (bottom row) shows
a band of decreased activity through the midportion of the left kidney , which remains relati vely
unchanged after 2 months. Subsequent studies showed no change over 4 additional months .
An area of contused parenchyma seen below the infarct shows marked improvement on the
2-month study. This patient is being followed closely for the possible development of hypertension.

parenchymal and pelvocalyceal tears (Fig 8), and the
chances of demonstrating it are increased if early and
late scintiphotos are obtained. Extrarenal c.ollections
such as retroperitoneal hematoma, urinoma, and
lymphocele (following renal transplant) cause voids
in the visualized background activity and distort the
urinary tract structures by their mass.
When total nonfunction of a kidney is seen on
urography, and 0 11 dynamic and static renal imaging
with a cortical agent, radiohippuran studies may be
useful in determining the presence of functioning
renal tissue. Hippuran I-131 is also useful in measuring renal function in cases where post-traumatic compromise is suspected and in following renal function
in these cases.
Radionuclide examination compares favorably
to angiography in detection and delineation of renal
injury. It is reportedly superior to aortography in
diagnosing mild to moderate renal injury such as contusion. Selective catheterization increases the
diagnostic accuracy of contrast angiography, but also

increases the morbidity of the procedure. Radionuclide imaging often is superior to urography in defining the extent of damage, and sometimes demonstrates injury that would be unsuspected from
urography alone. The development of ultrasonography
provides a method to determine the presence or absence of a kidney that shows no function on urography . This noninvasive technique, with the virtually
noninvasive radionuclide techniques described, can
decrease the instances when angiography is required
for renal evaluation after trauma.

IV. Peripheral Vascular Injury.
Dynamic imaging can be useful in evaluation of
acute vascular injury and its sequelae. The basic principle, as with other dynamic imaging procedures
described above, is rapid introduction of highspecific-activity radionuclide in a small volume (less
than 1 ml). Usually 99 mTc-pertechnetate is used.
However, when it is desirable to obtain multiple
views of an injured area, the first injection may be
made with a substance which is removed by an organ
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Fig 8-Renal laceration. Renal scintiphoto performed one minute
after injection of 99mTc-iron-ascorbate shows a "cold" area at the
lower pole of the right kidney. A follow-up study one hour later
clearly shows the laceration at the lower tip of the kidney with activity leaking into the area of hematoma.

during one pass through the circulation, for example,
by the liver. The background radioactivity is then reduced, and the second injection can be
made with pertechnetate. Scintiphotos are obtained
every 2 to 3 seconds for 15 to 25 seconds, and a static
image of 300,000 counts is obtained at conclusion of
the dynamic phase. A data processor allowing subsequent playback and analysis can be helpful in this as
in other dynamic examinations, but is not absolutely
necessary for clinical usefulness.
Extravasation into a paravascular hematoma
can be seen early as an irregular collection of activity
adjacent to a vessel. The activity may increase in intensity in static images. A well-defined circular area
of early increased activity in the vicinity of a major
vessel suggests pseudoaneurysm, not an uncommon
finding several weeks after trauma (Fig 9).
Traumatic arteriovenous fistula, as described in the
section on urinary tract injury, presents a picture of
early activity in the fistula and draining vein, with
early washout. Iatrogenic arteriovenous shunts for
dialysis can be studied in the same way. Traumatic
9 ~mTc-S-colloid

occlusion of an artery will cause deficient activity in
the area of its supply.
The venous system can also be visualized, if injection is made into the vein distal to the site of injury. Technetium-99m-MAA or microspheres are
used for venous studies. Collateral circulation and actual sites of thrombosis or other occlusion can be
demonstrated.
V. Skeletal Trauma.
The extensive use of radionuclide imaging in
benign bone disease is a relatively new phenomenon,
facilitated by the development of 99 mTc-labeled phosphate complexes (polyphosphate,
diphosphonate, and pyrophosphate). These compounds are relatively inexpensive, widely available,
have convenient physical characteristics, and yield a
low patient radiation dose, thus overcoming most of
the objectionable qualities of previously used compounds. The body of literature on radionuclide imaging findings in trauma is small, much of the experience having been gained incidentally in study of
malignant disease with 85Sr, s7 msr, and 18 F.
With the 99mTc agents, bone imaging is performed two to four hours after intravenous administration of 10 millicuries of the phosphate complex in
adults, or appropriately smaller doses in children.
Total body scanning with a high-speed, dual-probe
scanner or camera with moving table or detector accessories is desirable for potentially generalized
problems. Localized studies are usually performed on
the gamma camera, which yields high-resolution images with these compounds.
A useful area of examination in acute trauma is
in detection of a bone bruise or fracture that may be
difficult to detect radiographically, such as in the ribs,
or in the vertebral column (Fig JO). In children, fractures may be difficult to detect because of incomplete
ossification of the skeleton. Such sites of trauma can
be appreciated on imaging studies, which depend on
the hyperemia associated with reaction to trauma,
rather than on mineral density of the bone. The pattern of injury in the appropriate context may suggest
child abuse at a time when radiography is equivocal.
After two to three days, both actual fractures and
periosteal or superficial bone injury without fracture
may be "hot" despite negative radiographs (Fig 10).
The activity decreases in intensity over a period of
several months to years. The pattern of activity involving multiple bones can help distinguish trauma
from osteomyelitis, which also can cause intensely
"hot" uptake, but is not commonly multifocal.
Imaging is particularly valuable in following the
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Fig 9-Pseudoaneurysm of left peroneal artery after stab wound·. A .Angiogram demonstrates the presence of a large pseudoaneurysm with
arteriovenous shunting in the distribution of the left peroneal artery. B. Serial scintiphotos performed over the knee area following a bolus
injection of••mTc-pertechnetate reveal a large collection of activity which remains long after the vessels empty. A one-minute static cumulative image shown at the lower right contrasts with the background vascular activity in the muscle mass of the leg.

healing process after accidental fracture or iatrogenic
trauma such as osteotomy or bone graft. Activity
bridging the gap in the bone will appear before
radiographically visible bony bridging. Failure of this
to occur predicts nonunion or pseudarthrosis formation.
The possibility of aseptic necrosis of the femoral
head following subcapital fracture may be accurately
predicted by demonstrating diminished activity early,
with failure of activity to return after several weeks.
Revascularization of an area of aseptic necrosis
causes increased activity (11).
Artifacts of increased activity may be seen in soft
tissue injury such as incisions or organizing
hematomas, as well as in ectopic bone formation, following trauma and other insults. It is common to see
diffusely increased activity over the upper hemithorax
after mastectomy. Although this may be partly due to
decreased photon attenuation by the smaller mass of
overlying soft tissue, the absence of improved rib
definition suggests that it is actually soft tissue activity. It must be differentiated from tumor recurrence,

which can cause localized increased act1v1ty, and
from malignant pleural effusion. The latter is generally more diffuse and is present on both posterior
and anterior views.
Radiation injury to the bone, as to other organs,
ultimately causes a sharply defined field of
diminished uptake, although in the early postirradiation period, activity rriay be greater than normal.
The 99mTc-phosphates are excreted by the
kidney. Therefore, urine contamination must be
avoided, especially in bone imaging of the pelvis and
lower extremities, where it is likely to occur in the
severely ill patient. The bladder should be empty in
pelvic studies to avoid obscuring information.
VI. Chest Injury.
The methods of evaluating vascular and bone injury have already been described. Imaging has been
used in evaluation of hemothorax and _pulmonary
contusion, but these studies do not actually add to
the diagnostic capabilities of conventional radiography.
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A.

B.

Fig IO-Multiple spinal fractures seen on scintiphoto with only one fracture demonstrable on x-ray. The patient was a fireman who
leaped out of a window landing on his feet. A. Posterior "mTc-pyrophosphate bone scintiphoto 4 days after injury shows 4 active lumbar
vertebral bodies. B. Lateral lumbar spine x-ray shows disruption of L3 superior vertebral plate (arrow) . Multiple views failed to show any
other evidence of fracture.

Traumatic hemopericardium, like other pericardia! fluid collections, can be diagnosed by
demonstrating a clear "halo" around the heart,
separating it from lung and liver activity, during
dynamic and static studies after administration of I 0
to 15 millicuries of 99mTc-pertechnetate.
Fat embolism and "shock lung" cause multiple
perfusion defects or diffuse inhomogeneity of activity on routine lung imaging with 99mTc-labeled
macroaggregates of albumin or microspheres.
Although the imaging findings are indistinguishable
from pulmonary emboli of other etiologies, in the appropriate clinical setting the study may confirm the
diagnosis.
Inhalation studies with 133 Xe may help to
diagnose burns of the respiratory tract. Areas of
delayed filling and slow washout suggest obstruction
to air flow . This may be seen in chronic obstructive
lung disease, foreign body, or bronchiectasis, but in
the appropriate setting can confirm a suspicion of
tracheobronchial injury or edema related to smoke or
fume inhalation. If 133 Xe in saline is injected intravenously, perfusion defects can be documented,
and subsequent rebreathing permits evaluation of
ventilation patterns.
Conclusion. Radionuclide imaging provides
useful functional and anatomic information about
many orga n systems, especially when dynamic and
static phas.es are utilized. In any but the most acute
patient in need of immediate lifesaving therapy and
direct surgical intervention, these studies might well

be considered a routine part of the evaluation. In
many cases, invasive procedures such as angiography, myelography, and bronchography may be
avoided, or at least limited in time and extent. Acceptably low radiation doses make multiple and
follow-up studies reasonable.
By facilitating early treatment of traumatic injury in many cases, and by eliminating expensive and
complicated procedures in others, the more
widespread utilization of these techniques can help to
decrease the tremendous human and economic costs
of trauma .
Table I and T able 2 are adapted from Gilday and Alderson,
S eminars in Nuclear Medicine (4:3 57-370, 1974).
Figures 3 and 4 are reprinted from the Journal of Nuclear Medicine,
Vol. 14, No. 6, and Vol. 10, No. 10, respectively, with permission
o f publisher.
Figures 5 and 6 a re reprinted from Radiology (1 !0:419-425, 1974)
with permission of a uthors and publisher.
Figures 7 and 8 are reprinted from S eminars in N uclear Medicine
(4:117-132, 1974; 4:37 1-393, 1974, respectively) by permission of
Grune & Stratto n .
Figure 9 is reprinted from Radiology (109:623-628, 1973) with
permission of authors and publisher.
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Radioimmunologic Methods for Diagnosis of
Malignant Diseases
PAUL B. HOFFER, M.D.

Professor of Radiology and Director, Section of Nuclear Medicine, University of California Medical Center, San
Francisco, California

The recent availability of the carcinoembryonic
antigen (CEA) assay has stimulated great clinical interest in tumor antigens. Carcinoembryonic antigen
is not the only specific or tumor-associated antigen
currently identified . There are a number of other
tumor antigens which have been isolated, some of
which are related to CEA and some of which are
totally different. There is, for example, a nonspecific
cross-reacting antigen (NCA) which has been discovered in certain preparations which were considered
originally to be CEA. Nonspecific cross-reacting
antigen is a beta globulin (25% carbohydrate) which
cross-reacts with antibodies to CEA and may be
the nonspecific background element that causes the
CEA titer to be elevated in certain nonmalignant
diseases. There is also a membrane-associated, low
molecular weight tissular autoantigen (MT A) which
has been recently identified. However, this material
is not antigenetically related to CEA or NCA.
Carcinoembryonic antigen is an antigenetic
glycoprotein. The antibody-active site of this antigen
is actually in the glucose portion of the molecule
rather than the protein portion. Carcinoembryonic
antigen has a relatively high molecular weight
(200,000) and is soluble in perchloric acid. The perchloric acid solubility of CEA has greatly facilitated
extraction of the antigen from tumor tissue and is
also responsible for the relative convenience of the
current method of performing the radioimmunoassay for detection of this antigen.
Carcinoembryonic antigen is present in the
This is an edited transcription of a lecture presented by Dr.
Hoffer at the Postgraduate Course in Nuclear Medicine, February
27, 1975, in Williamsburg, Virginia.
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glycocalyx of malignant gastrointestinal cells and is
also present in fetal gastrointestinal tissues during the
first and second trimesters of fetal life. Gold and
Freedman discovered and isolated this material in
1965 (!). A radioimmunoassay for its detection was
developed soon after (2). Initial results with this assay
indicated that elevated blood CEA level was a specific
test for adenocarcinoma of the colon, although occasional patients with pancreatic carcinoma also had
elevated titers. However, more extensive clinical
studies indicate that circulating CEA is not only present in colonic and pancreatic malignancies but in
other malignancies as well, as noted by H. J. Hansen,
MD (oral communication, April, 1973). Unfortunately, CEA is also present in certain nonmalignant
disorders and some normal patients. the common
denominator in most cases of elevated CEA level associated with bowel disease is rapid cellular proliferation with disruption of the basement membrane. The
disruption of the basement membrane is important
because the antigen must leak into the circulation in
order to be detected. The cellular proliferation may
be responsible for the cell surface exposure of certain
primitive antigens that are not normally found in
adult human tissues . The upper limit of normal for
the currently available CEA assay is approximately
2.5 ng/ ml. However, a finite percentage of normal individuals will have CEA levels above this value.
Three percent of healthy, young nonsmoking
volunteers and 19% of smokers have CEA levels over
2.5 ng/ ml. There is some question as to whether the
smokers who do have elevated titers are not in fact
candidates for developing carcinoma of the lung,
although the evidence for this is currently speculative.
Former smokers have a fairly significant CEA titer
MCV QUARTERLY 11(3): 128- 130, 1975
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elevation. Thirty percent of patients with nonmalignant disease may have a titer above 2.5 ng/ml, and
10% of these patients have a titer above 5 ng/ml.
However, the assay shows more frequent and more
marked elevation of the antigen titer in patients with
malignancy, especially colorectal carcinomas. Eighty
percent of patients with colorectal carcinoma have a
titer greater than 2.5 ng/ml. Fifty percent have a titer
above 5 ng/ml. Other tumors such as lung carcinoma
are also associated with a high incidence of elevated
titer.
An early criticism of the CEA assay was the high
incidence of false-negative results in patients with
early-stage colonic carcinomas. The five-year survival
statistics for treated patients with Duke's stage A
colonic carcinoma is almost 100%. In the stage B
group, the survival is approximately 50% to 60%, and
in the stage C group (those patients in whom the
tumor has gone through the serosa and actually
metastasized to local nodes), the survival drops to
only about 25% at five years. Ideally, we would prefer
an assay that would detect 100% of patients with
colonic carcinoma, Duke's stage A (assuming that
most of these tumors do go through a progression
from stages A to C). However, using the current CEA
assay, only 20% of patients with stage A lesions will
have an elevated titer. In other words, 80% of the
patients with this type of lesion will have a normal
CEA titer. About 40% to 50% of patients with stage B
lesions will have positive titers. It is only when the lesion actually breaks through the serosa and is involving local nodes that the probability of an elevated
CEA titer approaches 90% to 100%. Therefore, the
current CEA immunoassay cannot be used alone as a
cancer-screening study. Its value in screening
patients, however, should not be totally discounted
since there is a significant five-year survival in treated
patients even in the stage B and C categories.
Doctor William McCartney, Mrs. Erika Lawrence,
and I performed a study at the University of Chicago,
comparing the relative value of the CEA titer to the
conventional colon examination for the diagnosis of
carcinoma of the colon (3). The study included almost
1,000 patients who were referred for radiologic colon
examination . Carcinoembryonic antigen titer above 3
ng/ ml (a level we arbitrarily selected to divide the
normal from abnormal groups) was detected in 15%
of patients subsequently diagnosed as normal, or
having inactive inflammatory bowel disease. There
was a 30% incidence of elevated titers in patients who
had cirrhosis and noncolonic malignancies. Less than
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10% of the patients with benign colonic polyps in this
series had significant titer elevation.
By comparison, the conventional radiologic colon
examination was positive, that is, showed evidence
for malignancy in only 10 out of 850 patients who
were subsequently established not to have colonic
malignancy. The colon examination was, therefore,
much more specific for excluding the diagnosis of carcinoma of the colon in patients subsequently proven
not to have colonic maiignancy.
Forty-eight of the patients in this series were subsequently proven to have carcinoma of the colon, first
diagnosed at the time of the study. The CEA titer was
normal in 16 of these patients and was abnormal in
only 67%, whereas the conventional radiologic colon
examination was abnormal in 90% of these patients.
The radiologic colon examination was, therefore,
clearly superior to the CEA test for detection of new
carcinomas of the colon. However, there were three
patients with carcinoma of the colon in this study in
whom the radiologic colon examination was originally considered to be normal or show signs representing
benign disease, who did have elevated CEA titers.
The CEA titer was potentially helpf~l in these cases
in raising the suspicion of colonic carcinoma. If the
results of the two tests are combined, the accuracy of
the diagnosis is 96%, which represents some improvement over the radiologic colon examination alone.
In active ulcerative colitis, the CEA level is frequently elevated and the level itself is not a useful clue
to detect early development of malignancy. The
patients with quiescent bowel disease usually have
· normal titers. In a patient with quiescent bowel disease, a rising CEA titer should be treated with great
suspicion for neoplasm.
Although the radiologic colon examination is
clearly superior for the initial diagnosis of colonic
malignancy, the CEA titer is equally superior for the
diagnosis of recurrence of colonic carcinoma. In our
studies of patients with recurrent colonic carcinoma,
only 2 of 15 patients with recurrence had a normal
CEA titer. The barium enema indicated recurrence in
only 3 of these 15 patients. The barium enema did
detect the two cases of recurrence with normal CEA
titers. Frequently, the recurrence of colonic carcinoma is not in the area of the primary tumor but
rather in the liver or elsewhere in the body. It is also
very difficult to distinguish postoperative changes in
the bowel from early recurrence of tumor on a conventional radiologic colon examination. These factors probably account for the poor detection rate of
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recurrence seen with the conventional radiologic
colon examination.
In summary, the CEA titer is not as sensitive as the
radiologic colon examination for the diagnosis of
primary carcinoma, but it is very useful in following
patients for recurrent carcinoma.
Another area of potential use for the CEA
radioimmunoassay is in the detection of metastatic
malignancy of noncolonic origin. The test is extremely useful when interpreted in conjunction with
other tests for metastatic disease. Doctor William
McCartney, Erika Lawrence, and I studied 368
patients who had both liver scans and CEA immunoassay (4). The liver scan is a useful test for the
detection of hepatic metastasis for many primary
malignancies; however, it has a 30% incidence of falsenegative results and a 10% to 20% incidence of falsepositive results. The false-positive cases are primarily
patients with other disorders such as cirrhosis, who
show lesions on the liver scan which closely mimic
metastatic tumor. In this study, we chose a level of 9
ng/ml as a dividing line between a positive result for
metastatic tumor and negative evidence for
metastatic tumor. It should be noted that this level is
considerably higher than the level usually selected for
detecting carcinoma of the colon .
Neither the liver scan nor the CEA assay was
perfect in detecting hepatic metastasis. However,
when the results of both tests were positive, the
probability that the patient had metastasis was
almost 100%, and when both tests were negative, the
probability of hepatic metastasis dropped to I%. If
the liver scan only was positive, the probability of
metastasis dropped to 60%, and if the CEA titer only

was positive, that is, above 9 ng/ ml, the probability
of hepatic metastasis was only 30%. These results suggest an important role of the CEA titer in evaluating
the patiepts with many types of tumors other than
colonic malignancy.
The continuing clinical use of the CEA titer will
undoubtedly reveal many other situations in which
the study is valuable. It is certainly not a diagnostic
panacea, and the results must be interpreted with
considerable caution. However, I believe we can look
forward to an era of continued expansion in this type
of tumor radioimmun oassay. More specific assays for
colonic tumor are being developed and will undoubtedly become available in the future. I am equally confident that similar assay techniques will be
developed for other types of malignancies.
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Pitfalls and Artifacts in Nuclear Imaging Studies
LEONARD M. FREEMAN, M.D .
Associate Professor of Radiology and Co-director of the Division of Nuclear Medicine, Albert Einstein College oj
Medicine , Bronx, New York

In interpreting scintillation images, one often is
confronted with a variety of deviations from the
typically normal study that need not represent definite pathology. Apart from normal anatomic variants
in the position, shape, or configuration of an organ,
one must also be prepared to appreciate alterations
due to the radiodiagnostic ageni employed and aberrations caused by faulty or improperly used instruments. Additionally, physiologic and/ or functional
changes associated .with specific organ studies have
provided a major source of error in routine image interpretation. It is the purpose of this article to acquaint (or reacquaint, as the case may be) the reader
with many of these problems so that they may easily
recognize them and, one hopes, improve their overall
interpretive abilities.
The discussion will follow the lines of general
considerations relating to instrumentation and
radiopharmaceuticals followed by specific organ considerations. In this type of review, some intentional as
well as some unintentional omissions may appear.
The author hopes that most of the common sources
of error have been included. Undoubtedly, soine
readers may think of other problems that they may
personally have been confronted with.
I. Instrumentation. Problems related to instrumentation may be related to malfunction of the
equipment oi: faulty technique.
A. Ma/function :
1. Lack offield uniformity. In using scintillation cameras, one must have a relatively
homogeneous response to gamma photons over the
From the Division of Nuclear Medicine, Department of
Radiology, Albert Einstein College of Medicine, Bronx, New
York, and presented by Dr. Freeman at the Postgraduate Course
on Nuclear Medicine, February 28, 1975, Williamsburg, Virginia.
MCV QUARTERLY 11(3): 131-144, 1975

entire crystal surface . A uriiform crystal with
properly balanced, normally functioning phototubes
is a prime requisite to proper image interpretation.
The response from different portions of the same
crystal may vary from one another by as much as 20%
to 30%. Computer programs have been written to
correct this problem . Since most individuals do not
have this facility, a simple field flood each morning
using a sheet source or separate Cobalt-57 sources,
with the collimator off, should, at least, help one appreciate what portions of the camera crystal are giving an inhomogeneous response. If the picture is particularly poor, the instrument should not be used and
the manufacturer's service department should be consulted .
2. Faulty spectrometer. An inability to properly
peak over the appropriate gamma photons of a
radionuclide is a flaw that obviously would prevent
one from obtaining a good image. Using the spectral
bands available on the Anger scintillation camera,
one should be able to appropriately "peak in" ori the
desired energy range. Using rectilinear scanners, one
should be able to obtain maximal count response if
the pulse height analyzer window is properly
positioned around the peak gamma photon energy.
3. Defects in the electronic circuitry (preamplifier, and other equipment) or display system
(cathode ray tube, and other equipment).
B. Technique:
Certain human errors also must be considered in
operating any electronic instrument.
1. Improper calibration. Even though an instrument may be functionally sound, electronic "drifts"
due to fluctuations in input voltage and other similar
factors may cause changes in the settings required to
obtain optimal response at a particular energy
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range. Frequent calibration checks by the technologist are needed to correct this difficulty.
2. Faulty settings for contrast enhancement, density, or time contrast. These are problems more often
associated with rectilinear scanners than stationary
cameras primarily related to the fact that there are
many more dials for the technologist to manipulate
on the former. Contrast enhancement settings deal
with the range of gray scale over which the counts
from the area being studied are spread. Too narrow a
range will create a very contrasted image which may
give a false impression of an abnormal area. The experienced interpreter should recognize this immediately. On the other hand, too little contrast
enhancement may, in some instances, mask abnormalities. Similar situations may exist for density settings which deal with duration of light flash and time
constant settings which deal with length of sampling
time for a particular event or position of the detector.
3. Information (count) density. This refers to the
amount of information one obtains in a unit area to
create an interpretable rectilinear scan image. Nowadays, we strive for count densities of 600 to 2000
counts per square centimeter. A simple formula used
to achieve this factor is as follows:
Count Density

= .

Maximal Count Rate
·

tain technical factors . Some general problems such as
low specific activity or concentration, poor compound labeling, presence of radionuclide impurities,
infiltration of the injected dose, and miscalculation of
the dose are applicable to all of the subsequently discussed clinical areas.
III. Brain Imaging. In brain scintigraphy, difficulties with both the radionuclide angiogram
(dynamic study) and blood-brain barrier study (static
study) may be encountered.
A. Radionuclide angiogram.
1. Jugular-venous reflux. A sudden Valsalva
maneuver by the patient during a rapid intravenous
bolus injection of a radiopharmaceutical can cause
the tracer to reflux up the jugular vein instead of
proceeding on its normal pathway to the heart (2).
This is recognizable as a band of activity entering the
head (sometimes into the transverse sinuses) well
before normal circulation time would fill the carotid
arterial tree (Fig I). It should not be misinterpreted as
asymmetric arterial flow. A second factor that may
cause such venous reflux is venous obstruction in the
upper thorax, for example, superior vena caval
obstruction, in which case reflux up the jugular represents the path of least resistance.
2. Expected asymmetries in elderly patients. Fif-

.

Scan speed X Line spacing

if one keeps the line spacing constant at 0.3 to
0.4 cm, a simple direct relationship between count
rate and usable speed is obtained. A simple technique
chart can be developed for the instrument operator
relating these factors to obtain a desired count density.
4. Improper collimator. The use of an improper
collimator can destroy an otherwise good study; for
example, a low energy 140 kev collimator cannot be
used for an 131 1-1-iippuran renal study since the 364
kev gamma photon of 131 1 will penetrate the collimator's lead septa causing considerable scatter
radiation resulting in loss of resolution and image
degradation.
Most of these aforementioned problems as weli
as several others are discussed at some length in a recent article by Harris (1 ).
II. Radfopharmaceuticals. Potential problems
with radiodiagnostic agents are encountered in each
individual organ-imaging area, and specific situations
will be primarily considered as each organ system is
discussed. These difficulties relate to both the
preparation of these different materials as well as cer-

Fig 1-Jugulo-venous reflux . A bolus of ••mTc-pertechnetate administered through a left antecubital vein is seen to reflux up left
jugular vein on 0-4-second scintiphoto. At 4-7 seconds, it has
refluxed back into transverse sinus and down right jugular vein. At
7-10 seconds, normal arterial flow to head is visualized.
Diminished right cerebral perfusion signifies presence of a right
cerebrovascular accident.
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teen to 20% of patients over the age of sixty can be expected to have asymmetric arterial flow solely on the
basis of normal arteriosclerotic change (3). No focal
neurologic findings are demonstrable in this group of
patients.
3. Bilateral carotid stenosis. The author has encountered two situations where bilateral carotid
artery stenosis has caused long delays in the cerebral
appearance of an antecubital intravenous injection of
99mTc-pertechnetate. Since an infiltrated injection
could cause the same finding, one should be aware of
this particular disease entity when encountering such
a study.
4. luxury perfusion in cerebrovascular accidents.
On occasion, increased rather than decreased flow
may be observed in a patient with an acute
cerebrovascular accident (3). This is believed due to
regional hyperemia and vasodilatation around the infarcted area. This phenomenon generally subsides
over a two- to four-week period. Such increased perfusion should not be misinterpreted as a vascular
malformation or neoplasm ,
B. Static brain studies:
I. Choroid plexus activity. The normal biologic
localization of radiopertechnetate in the choroid
plexus has been greatly emphasized (4, 5). Prior competitive blocking with potassium perchlorate has
greatly minimized this problem. If continuing difficulty exists, even after perchlorate block, a repeat
study with a different tracer such as 99mTc-DTPA
may be obtained. The question of whether or not
perchlorate premedication will prevent pertechnetate
uptake in an abnormal choroid plexus, for example,
papilloma or meningioma, has aroused some interest.
In general, most reports indicate that it will not interfere with uptake in choroid plexus lesions. This
was also the case in this author's large series of one
case (Fig 2).
2. Saliva artifacts. Since pertechnetate is actively picked up by the salivary glands and excreted
into the mouth, saliva artifacts must be watched for.
This is generally encountered in comatose or
semicomatose patients and children where drooling
may allow saliva to collect on different parts of the
head and neck (Fig 2). Repeat studies after cleansing
of the area should resolve the problem.
3. Prosthesis-metal plate, glass eye, and other
artificial parts. The relatively low gamma photon of
99mTc is easily attenuated by such foreign objects. The
old standbys of physical examination and plain skull
radiographs should clarify any suspicions in this area.
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Fig 2-Uptake in choroid plexus papilloma in a child unaffected
by potassium perchlorate premedication . Right lateral scintiphoto
at top shows intense uptake in a choroid plexus papilloma.
Pretreatment with perchlorate failed to block uptake in this abnormality. A follow-up study several months after radiotherapy is
shown at bottom. The lesion has decreased in size. The "hot" spot
on the back of the head is a salivary artifact caused by drooling.

4. Superficial pathology. The nonspecific uptake
of radiopertechnetate includes lesions of the skull and
scalp. Multiple views usually will clarify the problem since intracerebral abnormalities must be demonstrable on at least two images obtained at 90°
angles. Extracerebral but intracranial abnormalities
such as subdural hematomas, however, do not exhibit
the finding and may be difficult to differentiate from
more superficial pathology. Palpation of the scalp
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and skull radiographs should be used. Bony lesions
can be elucidated with 99mTc-labeled phosphate
studies. In addition, serial studies with 99mTcpertechnetate over a several-hour period may be
useful, since most intracranii!l abnormalities show increased uptake with time, while most bone and soft
tissue lesions seem to lose activity with time (6).
5. Previous surgery. Surgical flaps and other
defects may concentrate a tracer and show activity
for several years after an operation. It is useful to obtain a baseline study shortly after surgery. This makes
judgments on subsequent studies concerning
residual or recurrent abnormalities more lucid.
6. Vertex view artifacts. Mouth activity from the
tongue and oral mucous membranes may mask a
frontal lesion. Prior administration of atropine helps
diminish this. Obvious attention to this use of
atropine in problems of the elderly, for example,
glaucoma and urinary retention, should be given .
Visualization of the stomach on the vertex view in a
child has been reported to cause some difficulty as
well, since the appearance on that one view simulated
a neoplasm.
7. Need for serial studies after injection. Considerable emphasis has been placed on the need to obtain delayed scintigrams in many intracranial
problems, such as avascular primary neoplasms,
metastatic lesions, and extracerebral hematomas. By
confining the static brain scan to 45- or 60-minute

Fig 4-Misinjection in cisternography. Six hours after lumbar intrathecal administration of 131 1-Human Serum Albumin, no intracranial activity was detectable. This scan of the back shows the
column of tracer split instead of as a solitary column. This is the
appearance of subdural instead of subarachnoid injection.

Fig 3-Abnormal " mTc-pertechnetate brain image following a
stannous pyrophosphate bone image. This 4-view static study 2
days after a pyrophosphate bone scan demonstrates increased activity in all vascular structures (sagittal sinus, transverse sinus,
neck vessels, carotid siphon). The choroid plexus is particularly
well seen on left lateral view despite perchlorate premedication (see
text for explanation).

studies, one may miss or have to equivocate on some
lesions that often are well demonstrated on two- to
four-hour studies (7,8).
8. Abnormal pertechnetate brain scans following
bone scans. Several investigators have reported an
altered appearance of radiopertechnetate brain scans
performed one or two days following pyrophosphate
or polyphosphate bone studies (9, 10, 11). This consisted of abnormally increased activity in the area of
the sagittal sinus, transverse sinus, and choroid
plexus (Fig 3). It has been postulated that tin attaches
to red blood cells following bone imaging and subsequently administered pertechnetate undergoes intracellular reduction with labeling of the erythrocytes
during the brain scan (I 0). It is suggested that brain
scans should precede pyrophosphate bone scans or,
alternately, the brain scan, as the second procedure,
should be performed with 9 9mTc-DTPA.
9. Problems with cisternography. Only a couple
of problems will be discussed here. The first relates to
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mouth, creating the illusion of a CSF leak. Peaking
solely on the higher gamma photon (247 kev) of
111 In would guard against this.
IV. Bone Imaging. Within the past three years,
bone imaging has changed considerably primarily
because of the introduction of 99 mTc-labeled
phosphate compounds. Prior to the "phosphate" era,
Strontium-85 and subsequently 87 mSr and 18 F were the
radionuclides used.
I . Visualization of interfering colon activity with
85 Sr. This is the one difficulty associated with this
older radiopharmaceutical that will be discussed.
Because of a persistently high soft tissue and blood
background, 85 Sr studies generally were performed at
2 to 3 days following injection. At this delayed time,
the gastrointestinal tract represents the prime mode
of excretion . Laxatives should be administered prior
to performance of the study. On occasion, persistent
colon activity might mimic osseous uptake if it is
superimposed on a bony region such as the iliac wing.

Fig 5-Degradation of bony pelvic structures by bladder activity.
Upper posterior scintiphoto of pelvis was obtained 2 hours after
administration of••mTc-polyphosphate. Scatter from intense bladder activity severely degrades resolution of surrounding bony
structures. Marked improvement in image quality is seen after
patient voided and study was repeated (lower scintiphoto).

injection technique. If the intrathecally administered
material (nowadays, primarily m1n-DTPA) is placed
outside the subarachnoid space, for example, sub- or
epidural, no activity will reach the head. A scan of the
back showing a split, rather than solitary, column of
activity will confirm the suspicion of a faulty injection
(Fig 4).
In studying cerebrospinal fluid leaks, it often is
helpful to examine the patient in the same position in
which the leak is occurring. A recent report showed
an interesting artifact caused by residual 99 mTcpertechnetate activity from the previous day's brain
scan ( 12). It was in the region of the nasopharynx or

I
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Fig 6-Diffuse bony metastases with relatively normal-appearing
scan showing " missing kidney" sign . Patient with radiographically
demonstrated diffuse bony metastases from breast carcinoma.
Bony structures (except possibly the skull) appear normal on scan.
The absence of kidney visualization is the prime clue that an abnormality is present (see text for further explan ation).
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Repeat study after enema or a couple of days later
should help differentiate colon from true osseous activity.
2. Diminished resolution of normal pelvic structures due to bladder activity. This represents a basic
problem in all imaging procedures. It is particularly
well demonstrated in this area (Fig 5). The patient
should be asked to void immediately prior to starting
the scan. If bladder activity first presents as a
problem after a study is performed, a repeat examination of the area after voiding should be obtained.
3. Marginally active lesions missed due to excessive contrast enhancement. In bone imaging we
generally are searching for "hot" rather than "cold"
areas. In setting up a study, the technologist may, inadvertently, use an extremely active region, such as
the epiphysis in a child. This might prevent detection
of an abnormal , but not intensely active, focus in
another bony area in the same imaging field of view .
Coned-down camera views of a suspicious area often
are helpful.
4. Occasional false-negative studies in purely lytic or diffuse blastic lesions. The exact mechanism of
uptake of 99mTc-phosphates is unknown. Several
theories have been advanced which include ion exchange, chemisorption, and collagen uptake. In addition, blood flow and/ or concentration appears to
play a key role in delivering the radionuclide to the

Fig 7-" Photon Deficient" bone lesion. The patient was a young
girl with sickle cell disease and focal pain in distal right femur.
Anterior, lateral, and anterior pinhole magnification views are
shown for each distal femur. The area of mottled decreased activity
("cold" lesion) seen best on right lateral and right anterior pinhole
collimator views (arrows) is characteristic of bone infarction.
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Fig 8- Radioactive pulmonary emboli. Anterior, posterior, and
left lateral lung fields. (See text for explanation).

abnormal area . Most radiographically lytic lesions
will have a significant reparative (blastic) component
on histologic examination which would ensure their
detection by radionuclide study. On occasion, a
purely lytic lesion, for example, round cell sarcoma,
may be relatively quiescent histologically and might,
therefore, escape scintigraphic detection.
On the other hand, lesions that tend to have
diffuse osseous involvement, for example, prostate or
breast carcinomas, also might give false-negative
studies (13). In bone scintigraphy, we depend upon a
gradient between normal and abnormal uptake to
detect a lesion. In diffuse, uniform involvement, all
bones may be "hot" and such a gradient may not exist. One potential clue to the existence of such diffuse
involvement is a diminution or absence of renal activity (Fig 6) ( 14). Approximately 30% to 50% of the
administered dose of 99 mTc-labeled phosphate should
reach the skeleton with enough of the remaining activity going through the kidneys so that renal activity
on a two-hour study should be fairly intense.
Conceivably, lesions having hypermetabolic activity
might utilize more than their usual share of tracer,
thereby leaving only small amounts for the kidney.
This finding has been useful to the author and should
be looked for.
5. Photon deficient (" cold") lesions. On occasion,
abnormalities on bone scan may present as "cold"
rather than "hot" lesions (16). Complete interruption
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Fig 9-Interference of pleural fluid on dual-headed scanner study. Anterior scan (lower left) shows minimal diminution in right lung perfusion. Posterior scan (lower right) demonstrates much more severe apparent diminution in right lung activity due to interposed pleural fluid
shown on chest x-ray (see text for explanation).

of blood supply, as in bone infarction, is a major
cause of this finding (Fig 7). Other lesions such as occasional metastases and Legg-Calve-Perthes' disease
in children ( 17) also have shown this finding. In examining a bone scan, one, therefore, should be aware
of this alternate evidence of an abnormal lesion.

6. Asymmetries in chest activity due to radical
mastectomy. With reduced muscle mass following
mastectomy, the osseous structures on the involved
side appear more intense on the anterior scan (15). If
the asymmetry appears on both anterior and
posterior studies, a different explanation, such as
pleural fluid, should be sought. Once again, a history,
physical, and chest x-ray should solve any problems
in this regard.
7. Prosthesis, for example, pacemakers. As in
brain studies, overlying metallic or bulk objects such
as pacemakers will attenuate radiation and create a

void on scan. The characteristic rounded shape of a
pacemaker should help differentiate it from a possible
"photon deficient" lesion (see section 5 above).
8. Femoral vessel activity. Some patients, particularly in older age groups, will show linear bands
of increased activity medial to the femoral shafts. It is
felt that, in some cases, this may represent actual
changes in the femoral vessel wall. It may or may not
be associated with radiographic evidence of calcification.

V. Lung Imaging.
1. Radioactive "pulmonary emboli. " On occasion, large "hot" spots are seen on a lung scan (Fig 8)
(18). This finding is most often encountered in situations where difficult venipunctures have allowed excessive red cell and macroaggregate mixture time
in the syringe. Larger than usual aggregates ( 100µ to
1000µ) are formed which lodge in more proximal
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arterial beds causing these radioactive pulmonary
emboli. They are not of any clinical consequence, but
do interfere with interpretation. Their typical appearance should easily be recognized.
2. Macroaggregated hold-up on damaged endothelium. Visualization of axillary vessels on the side
of injection is sometimes noted; particularly in
patients who have had indwelling venous catheters
for a few days . The MAA or microspheres adhere to
the irritated endothelium of these vessels. Thrombosed vessels behave in the same fashion. This cannot
be used as a reliable indicator of lower extremity
venous thrombosis after foot injection because
venous stasis or insufficiency from other causes will
behave similarly ( 19).
3. Position during injection. Macroaggregated
albumin distributes along gravitational pathways in
normal lungs. Therefore, an injection performed in
an oblique, lateral, or upright position will result in a
different scan than one performed in a supine or
prone position .
4. Perfusion changes due to pulmonary venous
hypertension. In patients with left ventricular failure
and mitral heart disease, an anti-gravitational
phenomenon results in redistribution of perfusion.
The anterior and upper portions of the lung field will
exhibit greater activity than the posterior and lower
portions after a supine injection of MAA or
microspheres. The degree of change generally is
related to the severity of the pulmonary venous
hypertension associated with the disease process.
5. Free fluid distribution with dual-headed detectors. Free pleural fluid usually gravitates to the
dependent portion of a hemothorax which is that
portion away from the detector head of an Anger
camera or single-head rectilinear scanner. It will,
therefore, have a minimal effect on the observed perfusion pattern. However, when a dual-headed detector is used, the fluid will be interposed between the
lung and the lower detector. It often may cause a
"dampening" effect and an impression of generalized
decreased perfusion on the posterior scan only (Fig
9). Adherence to the cardinal rule of not interpreting
a lung scan without a concurrently obtained chest
radiograph should help avoid any problems.
6. Size discrepancies with dual-headed detectors.
In interpreting lateral lung scans performed with
dual-headed detectors, one should be aware of a
"shrunken" appearance occasionally encountered in
the "down" side of normal lungs. This is actually
caused by the fact that the "up" side is hyperex-

panded. The "down" side is actually expanding and
deflating more than the "up" side.
7. Loss of activity due to right-to-left shunt. The
presence of right-to-left cardiac shunts will cause a
loss of pulmonary activity. The finding of kidney
activity should arouse some suspicion. In children
with known large, right-to-left shunts, careful consideration should be given to the advisability of performing the lung scan. The prime reason for this is
possible complications from the shunting of the
macroaggregates to the brain .
In patients who have had surgically created
shunts, details of the shunt anatomy will help the interpreter of the study determine if the particles are
distributing the way they should.
VI. Liver Imaging.
1. Altered distribution due to colloid particle size.
Technetium-99m-sulfur colloid particles ( ~ 100-400
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Fig 10-Subphrenic abscess simulating intrahepatic lesion. On this
combined anterior liver-lung study, a massive concave defect is
seen on right lateral border of hepatic activity. It appears as if some
liver parenchym a is superior to the defect. The initial impression in
this postoperative febrile patient was that of an intrahepatic
abscess. At repeat laparotomy, the collection was completely extrahepatic and had displaced the liver medially .
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mµ) are 10 to 20 times larger than gold-198 colloid
particles (10-20 mµ). Although the vast majority of
these larger particles still localize in the liver, a significantly greater proportion also will be phagocytized
by the spleen's reticulo-endothelial system (20). In
other words, we routinely image the spleen on 99mTcsulfur colloid studies, whereas this was not the case
on 198Au scans. Increased splenic visualization was a
significant indicator of diminished hepatic perfusion
on 198Au studies. Because of the normally different
distribution, this finding is not as sensitive an indicator of decreased liver blood flow on 99mTc-colloid
studies.
2. Considerable anatomic variation in normal
liver. The liver scan is regarded by most nuclear
medicine physicians as one of the most difficult to interpret. The tremendous variation that one encounters in the normal liver is a major contributing
factor to this problem (21). Such variants as Riedel's
lobe, left lobe thinning, high hemidiaphragms, interposed colon, and gallbladder fossa must be fully appreciated by the nuclear medicine physician before he
can interpret hepatic scintigrams intelligently.
3. Extrinsic pressure deformities from neighboring organs and structures. Because of its great
pliability, the liver's shape and configuration may be
easily altered by normal variants or disease processes
in neighboring organs and structures (22). Any
process in the retroperitoneal area, for example,
kidney or pancreas masses; intraperitoneal area, for
example, high hepatic flexure of colon or subphrenic
abscess; or intrahepatic area, for example, dilated
gallbladder or bile ducts, can cause apparent hepatic
defects that are often indistinguishable from true intrahepatic space-occupying lesions (Fig 10). An appreciation of this possibility and correlation with
physical findings and other radiographic examinations are helpful in elucidating such problems.
4. Apparent defects due to attenuation of the
gamma photons. As in other organ areas, overlying
objects such as pacemakers, breast prostheses, and
other objects may cause defects int.he image. Physical
examination at the time of study will assist the interpreter.
5. "Pseudomasses" in cirrhosis and hepatitis.
Focal defects simulating space-occupying lesions may
be encountered in patients with diffuse parenchymal
problems such as cirrhosis or hepatitis. In cirrhosis,
such defects have been attributed to fibrosis, atrophy,
shunting, and nonfunctioning areas of regenerative
nodulation (23). The potential existence of a
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hepatoma in such a "cold" area presents a problem
that generally may be solved by performing a
radionuclide angiogram with pertechnetate and/ or
75 Se-selenomethionine
or 67Ga-citrate metabolic
studies. Hepatomas usually will be active with each
of these tracers while almost all cirrhotic pseudomasses will not.
Less well appreciated is the pseudomass of
hepatitis which appears to be due to nonuniform involvement of the disease process. Focal, severt swelling of the polygonal cells somehow appears to compromise function of much less prevalent R-E cells
(24) (Fig 11).
6. Hyperconcentration of colloid in occasional lesions. "Hot" spots in the liver have been reported by
several investigators. Most of these cases have been
instances of venous obstruction, for example,
superior vena caval, where umbilical collaterals
crossing over the anterior surface of the liver in the
interlobar area locally deposit a large amount of col-
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Fig. 11-Pseudomass in acute viral hepatitis. Upper row of 99mTcsulfur colloid scintiphotos were performed in a 15-year-old, deeply
jaundiced girl. An apparent space-occupying defect is seen in the
right lobe. Liver biopsy of this area showed markedly swollen
hepatocytes and a striking paucity of K upffer's cells. The appearance was consistent with viral hepatitis. Middle and lower row
of scintiphotos were obtained 6 weeks and 6 months later, respectively, and show a gradual return to normal.
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loid (25). Two specific intrahepatic lesions that have
shown "hot" rather than "cold" areas are abscess
and hemangioma, the former because of R-E stimulation by the sepsis and the latter because of the
markedly increased number of venous sinusoids with
their associated R-E cells. Since we generally think of
focal hepatic lesions as "cold" areas, one should remain attuned to this variant of the abnormal study.
Recognition of its presence should make one feel a bit
better after he or she has misinterpreted several
hepatic masses.
7. Renal concentration in 1311-rose bengal studies.
Under normal circumstances, less than 5% of
radioiodinated rose bengal is excreted by the kidneys.
In patients with extrahepatic biliary obstruction or
severe hepatic parenchymal disease, considerably
more of the activity appears in the urine (26). This is
particularly true in the former group of patients.
Most likely it is free 131 I dissociated from the rose
bengal that is appearing in the urine. With higherthan-normal levels of renal activity, the kidneys may
be visualized on rose bengal abdominal scans (Fig

Fig 12-Renal concentration of radioiodinated rose bengal.
Radioiodinated rose bengal scans on 68-year-old female with pancreatic carcinoma. A. t-hr study demonstrates typical pattern of
renal excretion (arrows). Because of its presence on this early scan,
confusion with intestinal activity could easily lead to mistaken impression of patent biliary tract. 20/5 min clearance is 24% (normal
= > 35% ). B. Serial scans, including this 24-hr study, reveal intensification, but no change in position of extrahepatic activity,
confirming fact that activity represents kidneys (arrows). Upper
half of right kidney is obscured by overlying hepatic activity.
Failure of dye to leave liver supports impression of extrahepatic obstruction despite moderately impaired liver function
(20/5-min blood clearance of 24%. C. 24-hr right lateral scan
shows kidney in normal position posterior to liver.
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12). This finding must be differentiated from intestinal activity to avoid an erroneous interpretation
of a patent biliary tract. This may be achieved by
noting the following:
a. Bilaterality of renal activity
b. Same position, but more intense activity on
follow-up studies
c. Posterior position on lateral study
d. Same position as kidneys on urogram or
renal scintigram (if a, b, or c do not answer the
question)
8. Altered 131/-rose bengal excretion patterns due
to fistulae and shunts. In naturally occurring, for example, cholecystocolonic, fistula or surgically
produced shunts, for example, Longmeyer proced~
ure, the rose bengal may escape the liver through
an alternate pathway even though the biliary ducts
may be obstructed. Careful observation of the time of
transit as well as the pattern of extrahepatic activity
are important considerations, as is the presence of a
surgical history.
VII. Spleen Imaging.
1. Bipartite spleen. Similar to other organs, the
spleen is subject to considerable variation in its normal shape and configuration. Lobulation and notches
are frequent findings. On occasion, the spleen presents in two distinct pieces-the so-called "bipartite"
spleen. In patients who have had left upper quadrant
trauma, this may be a particularly troublesome
finding that may require contrast angiography for
clarification.
2. Overlap of left lobe of liver with spleen
simulating a defect. In many patients the left hepatic
lobe overlaps the upper splenic border and can cause
an apparent defect on the superolateral border of the
spleen (Fig 13). This is a very common pitfall that is
frequently misinterpreted as a significant splenic lesion, particularly in trauma cases. Oblique views may
not successfully separate the organs. We have found ·
that a 30° caudad-angulated view with the patient in
the prone position best separates the liver and spleen
(27).
3. Accessory spleen masked by overlying left lobe
of the liver. If a patient has had a therapeutic splenectomy for a hematological disorder, for example,
idiopathic thrombocytopenia purpura, and continues
to have difficulties, the presence of an accessory
spleen must be excluded. Searches for such splenic
tissue generally are undertaken with 99IllTc-sulfur colloid as the initial tracer. Since this radiopharmaceutical is not spleen-specific, activity in the left
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Fig 13-0verlap of left hepatic lobe and spleen simulating a
splenic defect. On the initial study (top) in this 24-year-old male
with a left upper quadrant stab wound, an apparent defect (arrow)
is noted in the superolateral margin of the spleen. A slight obliquity (bottom) successfully separates left lobe of liver and spleen indicating that the suspect lesion was caused by an overlap of the two
organs. Note that the medial portion of left lobe of liver (arrow)
appears thinned due to attenuation of the photons by spine.

hepatic lobe conceivably might mask a splenunculus.
Therefore, if the colloid study fails to demonstrate a
spleen, a repeat study with 99 mTc-or 51 Cr- labeled to
heat denatured erythrocytes is needed. The tagged red
cells are selectively sequestrated by splenic tissue,
and no interfering hepatic activity is encountered.
VIII. Pancreas Imaging.
I. Poor visualization in fasting or debilitated
patients with a normal pancreas. Poor visualization of
the pancreas on a 75 Se-selenomethionine study may
reflect either disease or merely not enough pancreatic
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stimulation (28). The patient should be prepared with
overnight fasting followed by a well-balanced test
meal. This will promote a profuse production of pancreatic enzymes and good uptake of the
selenomethionine in most normal individuals (28).
Absence of activity after such a protocol may be interpreted as pancreatic disease with a greater degree
of confidence.
2. Overlapping liver activity. This is particularly
troublesome in patients with hepatomegaly. Angling
of the detector head towards the right upper
quadrant as well as angulating the patient by raising
the left flank and shoulder is a useful maneuver to
correct this problem (28). The best solution is the use
of subtraction technology, if it is available.
3. Variations in shape and configuration of normal pancreas. The pancreas may exist in the
transverse, pistol-shape, oblique, or horseshoe configurations. Sometimes, a defect is present in the midbody region as a result of the aorta or spine crossing
over and thinning out the functioning tissue. Serial
camera scintiphotos may show a changing concentration of activity in this region (28). Radionuclide aortography also may be used to correlate the aorta's
position with the apparent defect on the scintigram.
IX. Kidney Imaging.
I. Size discrepancies on erect and prone studies.
Ptotic kidneys may rotate on anteroposterior axis in
the erect position. This foreshortening effect creates
an impression of a smaller kidney when studied in the
erect or sitting up position. Prone studies provide a
safer means of assessing renal size.
2. Free radiopertechnetate in the stomach when
using 99 mTc-labeled agents. Most renal agents are
prepared by reducing 99 mTc from the +7 to +4
valence state with tin or some other suitable material.
Pertechnetate ( + 7 state) may persist on rare occasions and its normal biologic localization in gastric
mucosa may confuse interpretation of left kidney activity (29). Similarly, free 131 1 may localize in the
stomach on radioiodinated hippuran renal studies.
3. Liver accumulation of chlormerodrin in
azotemia. When 197 Hg-chlormerodrin is used in renal
studies, a small amount of hepatic activity usually is
present. In azotemic patients, hepatic activity increases at the expense of renal excretion. Merging
hepatic and renal activity may be misinterpreted as a
large right kidney. As the azotemia worsens, the
ability of the kidney to concentrate chlormerodrin is
completely lost (Fig 14). At this stage, intense liver
activity may be misinterpreted as a solitary right
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kidney. In severe azotemia, 1311-orthoiodohippurate
is the agent of choice and its use should avoid any of
the aforementioned problems (Fig 14).
4. False results after urography or angiography.
High doses of organic iodides in the form of
radiographic contrast media often cause transient
changes in renal function that will effect the kidn.ey's
ability to concentrate subsequently administered
radiopharmaceuticals. This is particularly true in
patients with obstructive uropathy and, also, after
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Fig 14-Pitfall in scanning azotemic patients with 197 Hg
chlormerodrin. Patient shown had blood urea nitrogen of 112
mg/100 ml and plasma creatinine of 5.5 mg/ 100 ml. The "'Hg
chlormerodrin (top) has all been excreted by the liver. No renal
concentration is evident. A frequent misinterpretation of this study
is an enlarged solitary right kidney. The 131 1-Hippuran study (bottom) is successfully concentrated in both kidneys which are slightly
smaller than riormal.

selective renal artery studies . Optimally, the
radionuclide studies should precede the radiographic
studies. If this is not feasible, an interval of three or
four days should be obtained between the studies.
X. Thyroid Imaging.

1. Poor uptake and image due to saturated iodine
pool. In patients who have been taking iodidecontammg medications or who have had
radiographic examinations with organic iodide contrast media, the iodine pool is saturated. Subsequent
administrations of tracer amounts of radioiodine
within a few days will result in poor uptakes and images.
2. Failure to palpate nodules at the time the scan
is performed. A vague history of a palpated nodule in
the right lobe is insufficient data to accurately assess
whether the nodule is functional or not. Nodules
should be palpated with the immobilized patient on
the scanning bed. It should then be transcribed directly
to the scan image. Such one-to-one relationships are
best obtained with rectilinear scanner. By knowing
exactly where a nodule is, one is able to offer an accurate interpretation. In order for a nodule to be considered functional, it must concentrate greater activity than the surrounding tissue.
3. Pertechnetate uptake in nodules "cold" on
iodine scans. The categorization of functional or nonfunctional nodules is a radioiodine classification .
Pertechnetate is handled quite differently from iodine
in that the thyroid traps, but does not organify it.
Therefore, a nodule may exhibit activity with the
former, but not the latter (Fig 15). Such a nodule is to
be considered "cold" and conceivably may represent
a carcinoma. All nodules of the thyroid should be
evaluated with radioiodine.
4. Retrosternal functioning tissue unappreciated
with low-energy gamma nuclides. lodine-125 has
achieved some popularity as a thyroid imaging agent.
Since it possesses very low energy imaging photons
( ~ 27 kev), it is inappropriate for studies in the
thorax, for example, to search for retrosternal goiter.
Although 99mTc-pertechnetate with its 140 kev gamma photon or 123 1 with its 190 kev gamma photon
may suffice, the 364 kev gamma photon of Iodine131 appears best for this specific purpose.
XI. Blood Pool Studies.
1. Excessive contrast enhancement on rectilinear
scan cardiac blood pool studies. The detection of a
pericardia) effusion using the rectilinear scanning
method depends upon a comparison of the transverse
diameters of the cardiac blood pool activity and the
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When 113m1n chloride is used as the tracer for a blood
pool study (particularly placental localization), it
binds in vivo to transferrin, a serum globulin that is
essential to the transport of iron. In cases of excessive
iron ingestion or hemochromatosis, the transferrin
receptor sites are bound. Subsequently administered
usmrn chloride will remain unbound and will appear
in the kidneys. The desired blood pool will not be
w~ll visualized (31 ).
Case shown in Figure 8 courtesy Charles J . Blatt, MD.
Figure 11 is reprinted from the Journal of Nuclear Medicine,
Vol. 14, No. 8, with ·permission of publisher.
Figure 13 is reproduced with permission from Radiology
(110:419-425, 1973).
Figure 15 is reproduced from Atkins H , The Thyroid
in Clinical Scintillation Imaging, Freeman LM, Johnson PJ (eds),
New York, Grune & Stratton, 1975, by permission.
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Correction Notice: On p . 76 of the MCV / Q 11 :2, 1975, Nuclear Medicine-Part I,
the first sentence of section 5 should have read, "Adequate assessment of both single
and multiple nodules in the thyroid gland require that a scan be performed after the
administration of 131 1 (4), 123 1 (5) if available, or 99 mTc (6)."
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relief. Ta lwi n can be compared to codeine in ana lgesic efficacy: one 50 mg. tablet appears equiva lent
in ana lgesic effect to 60 mg. (1 gr.) of codeine. However, patients receivingTa lwin Tablets for prolonged
periods face fewer of the consequences you 've come
to expect with narcotics. There shou ld be fewer
"adverse effects" on her way of life.
Tolerance rare: Tolerance to the analgesic effect of
Ta lwin Tablets is rare.
Dependence rare: During three years of wide clinical use, there
have been a few reports of dependence and of withdrawal symptoms wi th orally administered Ta/win. Patients with a history
of drug dependence should be under close supervision while
receiving Ta/win orally.
In prescribing Ta/win for chronic use, the physician should
take precautions to avoid increases in dose by the patient and
to prevent the use of the drug in anticipation of pain rather
than for the relief of pain.*

Generally well tolerated by most patients*: Infrequent ly causes
decrease in blood pressure or tachycardia; rarely causes respiratory depression or urinary retention; seldom causes diarrhea
or constipation. Acute, transient CNS effects, described in
product information on fo llowing page, have occu rred in rare
instances fo llowing t he use of Ta lwin Tablets. If dizziness,
lightheadedness, nausea or vomiting are encountered, these
effects may decrease or disappear after t he first few doses.
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Chances are, the same 50 mg. Talwin Tablet you
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relief. Talwin can be compared to codeine in analgesic efficacy: one 50 mg. tablet appears equivalent
in analgesic effect to 60 mg. (1 gr.) of codeine. However, patients receiving Talwin Tablets for prolonged
periods face fewer of the consequences you 've come
to expect with narcotics. There should be fewer
"adverse effects" on her way of life.
Tolerance rare: Tolerance to the analgesic effect of
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Dependence rare: During three years of wide clinical use, there
have been a few reports of dependence and of withdrawal symptoms with orally administered Ta/win. Patients with a history
of drug dependence should be under close supervision while
receiving Ta/win orally.
In prescribing Ta/win for chronic use, the physician should
take precautions to avoid increases in dose by the patient and
to prevent the use of the drug in anticipation of pain rather
than for the relief of pain.*

Generally well tolerated by most patients*: Infrequently causes
decrease in blood pressure or tachycardia ; rarely causes respiratory depression or urinary retention; seldom causes diarrhea
or constipation. Acute, transient CNS effects, described in
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lightheadedness, nausea or vomiting are encountered, these
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Analgesic for Oral Use
Indication: For the relief of moderate to severe pain.
Contraindication: Talwin should not be administered to patients

who are hypersensitive to it.
Warnings: Drug Dependence. There have been instances of psychological and physical dependence on parenteral Ta/win in patients with a history of drug abuse and, rarely, in patients without
such a history. Abrupt discontinuance following the extended use
of parenteral Ta/win has resulted in withdrawal symptoms. There
have been a few reports of dependence and of withdrawal symptoms with orally administered Ta/win. Patients with a history of
drug dependence should be under close supervision while receiving Ta/win orally.
In prescribing Ta/win for chronic use, the physician should take
precautions to avoid increases in dose by the patient and to prevent the use of the drug in anticipation of pain rather than for the
relief of pain.
Head Injury and Increased lntracranial Pressure. The respiratory
depressar:t effects of Talwin and its potential for elevating cerebrosp;nal fluid pressure may be markedly exaggerated in the pres~nce of ~ea~ injury., other intracranial lesions, or a preexisting
increase in 1ntracran1al pressure. Furthermore, Talwin can produce effects which may obscure the clinical course of patients
with head injuries. In such patients, Talwin must be used with
extreme caution and only if its use is deemed essential.
Usage in Pregnancy. Safe use of Talwin during pregnancy (other
than labor) has not been established . Animal reproduction studies
have not demonstrated teratogenic or embryotoxic effects. However, Talwin should be administered to pregnant patients (other
thar: labor) qnly wher:. in the jud~ment of the physician, the potential benefits outweigh the possible hazards. Patients receiving
Talwin during labor have experienced no adverse effects other
than those that occur with commonly used analgesics. Talwin
~hould be used with caution in women delivering premature
infants.
Acute CNS Manifestations. Patients receiving therapeutic doses
of Talwin have experienced, in rare instances, hallucinations (usually visual), disorientation, and confusion which have cleared
spontaneously within a period of hours. The mechanism of this
reaction is not known . Such patients should be very closely observed and vital signs checked . If the drug is reinstituted it should
be done with caution since the acute CNS manifestations may recur.
Usage in Children. Because clinical experience in children under
12 years of age is limited, administration of Talwin in this age
group is not recommended .
AmbulaJory Patients. Since sedation, dizziness, and occasional
euphoria have been noted, ambulatory patients should be warned
not to operate machinery, drive cars, or unnecessarily expose
themselves to hazards.
Precaut~ons: Certain Respiratory Conditions. Although respiratory
depression has rarely been reported after oral administration of
T~lwin, t~e drug should .be administered with caution to patients
with respiratory depression from any cause, severely limited respiratory reserve, severe bronchial asthma and other obstructive
respiratory conditions, or cyanosis.
Impaired Renal or Hepatic Function. Decreased metabolism of the
drug by the liver in extensive liver disease may predi spose to
accentuation of side effects. Although laboratory tests have not
indicated that Talwin causes or !ncreases r~nal or hepatic impairment, the drug should be administered with caution to patients
with such impairment.
Myocardial Infarction. As with all drugs, Talwin should be used
with caution in patients with myocardial infarction who have nausea or vomiting.
Biliary Surgery. Until further experience is gained with the effects

of Talwin on the sphincter of Oddi, the drug should be used with
caution in patients about to undergo surgery of the biliary tract.
Patients ~eceiving Narcotics . Talwin is a mild narcotic antagonist.
Some patients previously given .narcotics, including methadone for
th.e dally treatment of narcotic:: .dependence, have experienced
withdrawal symptoms after rece1v1ng Talwin.
CNS Effect. Caution should be used when Talwin is administered
to patients prone to seizures; seizures have occurred in a few such
patients in association with the use of Talwin although no cause
and effect relationship has been established.
Adverse Reactions: Reactions reported after oral administration of
Talwi~ ir:clude gastrointestinal:. nausea, vomiting; infrequently
const1pat1on; and rarely abdominal distress, anorexia diarrhea .
CNS eftects: dizziness, lighthead.edness, sedation, euphoria, headache; infrequently weakness, disturbed dreams insomnia syncope, visual blurring and focusing difficulty, haf lucinations (see
Ac.ute .C.NS Ma.nifestatiorys 1:1nder WARNINGS); and rarely tremor,
1mta~ll1ty, excitement, ~1nn1tus . A1:1tonomic: sweating; infrequently
flu~hin~; and rarely chills. Allergic: infrequently rash; and rarely
urt1carii:!, edema of the face. Cardi<;wascu/ar: infrequently decrease in blood pressure, tachycardia. Hematologic: rarely depressi~n of white blood cells (especially granulocytes) usual ly
rev.ers1ble and usually associated with diseases or other drugs
which ar.e. known to cause su.ch changes, moderate transient
eos1noph1l1a. Other: rarely respiratory depression urinary retention, toxic epidermal necrolysis.
'
Dosage and Administration: Adults. The usual initial adult dose is
1 tablet (50 mg.) every three or four hours. This may be increased
to 2 tablets (100 mg.) when needed. Total daily dosage should not
exceed 600 mg.
When antiinflammatory or antipyretic effects are desired in addition to analgesia, aspirin can be administered concomitantly with
Talwin.
Children Under 12 Years of Age. Since clinical experience in children under 12 years of age is limited, administration of Talwin
in this age group is not recommended.
Dura.tion of Therapy. Patients wit.h chronic pain who have received
Talwin orally for prolonged periods have not experienced with~rawal symptoms even when administration was abruptly discontinued (see WARNINGS). No tolerance to the analgesic effect has
b~en observ~d. Laboratory tests of blood and urine and of liver and
kidney function have revealed no significant abnormalities after
prolonged administration of Talwin .
Overdosage: Manifestations. Clinical experience with Talwin overdosage has been insufficient to define the signs of this condition.
Treatme_nt. Oxygen, intravenous fluids, vasopressors, and other
supportive measures should be employed as indicated. Assisted
or controlled ventilation should also be considered . Although
nalorph1ne and levallorphan are not effective antidotes for respiratory . depression due to overdosage or unusual sensitivity to
Talw1n, P!3ren.teral na.lqxone (Narcan®, avai lable through Endo
Laboratories) 1s a spec1f1c and effective antagonist.
Talwin is not subject to narcotic controls.
How Supplied: Tablets, peach color, scored . Each tablet contains
Talwin (brand of pentazoc ine) as hydrochloride equivalent to
50 mg. base. Bottles of 100.
Winthrop Laboratories, New York, N.Y. 10016 @~.IZ7:eJ
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The American Association for the Study of Headache
announces

THE ELEVENTH ANNUAL
HAROLD C. WOLFF, M.D.
LECTURE AWARD
which will be awarded to the physician who submits the best original paper on
headache, head pain, or on the nature of pain itself. The paper may be concerned
with basic research, clinical studies, or both. All physicians, including those in
training as fellows or residents are eligible. Winner of the 1975 award is Ottar
Sjaastad, M.D., Oslo, Norway for his paper, "Histamine and Its Relation to
Vascular Headache, With Particular Reference to Cluster Headache"

A prize of $1,000 will be awarded to the recipient of the lectureship, and he will be
invited to present the paper at the annual meeting of the American Association for
the Study of Headache. The next annual meeting will be held at the SheratonDallas Hotel in Dallas, Texas on June 26-27, 1976 .
The papers will be judged by the Editor and Associate Editors of the journal,
Headache. Papers should be submitted in duplicate in accordance with that journal's editorial instructions. Those papers which do not win the prize, but which
are deemed worthy of publication may be published in the journal at the
discretion of the editorial board. Similarly, authors of these papers may be invited to present their work at the annual meeting, at the discretion of the
program committee. The judges reserve the right not to make the award if no
paper submitted is considered worthy of it.
Papers should be submitted to:
Otto Appenzeller, M.D., Ph.D.
Department of Neurology
UNM School of Medicine
1007 Stanford Drive N.E.
Albuquerque , N.M. 87131
Deadline for submission of papers is March 1, 1976.

The support of Sandoz Pharmaceuticals is gratefully acknowledged.

A service to medical education from A. H. Robins:
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on physical examination
of the abdomen:

Normally palpable organs:
the edge of the liver descending,
on inspiration, below the costal
margin (A); the lower pole of the
right kidney (8); the abdominal
aorta (CJ; the descending colon
and the sigmoid (DJ; the ascending colon (E); and occasionally
the bladder (though rising of
this organ beyond the pubis
does not necessarily indicate
disease).
Impossible to outline, unless
diseased , distended or enlarged:
the gallbladder, pancreas.
stomach, small intestine, transverse colon and spleen.

I

-£l

The A . H . Robins G .I. Series consists of six booklets, designed to provide a Quick, yet comprehen1 •
sive review of basic procedures and practices in
G.I. medicine - with particular emphasis on the
physical examination as performed in the office or
~
at bedside . If you have teaching responsibilities.
limited Quantities are available: Part 1 - lnspeclion,
...:.,
Part 2 - Palpation , Part 3 - Percussion . Part 4 - Auscultation. Part 5 Abdominal Pain and Part 6 - Dilferent1al D iagnosis of Abdominal
Disorders. Write to: The Medical Department, A . H . Robins Company,
1407 Cummings Drive. Richmond . Virginia 23220 .
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Normally palpable organs:
the edge of the liver descending,
on inspiration, below the costal
margin (A); the lower pole of the
right kidney (BJ; the abdominal
aorta (CJ; the descending colon
and the sigmoid (DJ; the ascending colon (EJ; and occasionally
the bladder (though rising of
this organ beyond the pubis
does not necessarily indicate
disease)
Impossible to outline, unless
diseased , distended or enlarged :
the gallbladder, pancreas.
stomach, small intestine, transverse colon and spleen.

each tablet.
capsule or 5 cc.
teaspoonful
each
olehxir
Don natal
each
(23% alcohol)
Extentab
No 2
hyoscyamine sulfate
O 1037 mg.
0.1037mg
031 11 mg.
atropine sulfate
0.0t94 mg
0.0194 mg.
0.0582mg
hyosc1ne hydrobromide
0.0065mg
00065mg.
0.01 95mg.
Phenobarbital
(V.. gr.) 16.2 mg. (112 gr.) 32.4 mg. (%gr.) 48.6 mg.
,warning may be habit forming)

Brief summary. Adverse Reactions: Blurring of vision. dry mouth,
difficult urination. and flushing or dryness of the skin may occur
on higher dosage levels, rarely on usual dosage Contraindications: Glaucoma; renal or hepatic disease; obstructive uropathy
(for example, bladder neck obstruction due to prostatic hypertrophy); or hypersensitivity to any of the ingredients.
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Brief summary. Adverse Reactions: Blurring of vision , dry mouth,
difficult urination, and flushing or dryness of the skin may occur
on higher dosage levels, rarely on usual dosage Contraindications: Glaucoma; renal or hepatic disease. obstructive uropathy
(for example, bladder neck obstruction due to prostatic hypertrophy); or hypersens1tiv1ty to any of the ingredients.

A·H·RO BINS

A H Robins Company. Richmond. Virginia 23220

Before prescribing, please consult
complete product information, a summary of which follows:
Indications: Tension and anxiety

states, somatic complaints which are
concomitants of emotional factors; psychoneurotic states manifested by tension,
anxiety, apprehension, fatigue, depressive symptoms or agitation; symptomatic
relief of acute agitation, tremor, delirium
tremens and hallucinosis due to acute
alcohol withdrawal; adjunctively in skeletal muscle spasm due to reflex spasm to
local pathology, spasticity caused by
upper motor neuron disorders, athetosis,
stiff-man syndrome, convulsive disorders
(not for sole therapy) .
Contraindicated: Known hyperserisitivity to the drug. Children under 6
months of age. Acute narrow angle glaucoma; may be used in patients with open
angle glaucoma who are receiving appropriate therapy.
Warnings: Not of value in psychotic
patients. Caution against hazardous
occupations requiring complete mental
alertness. When used adjunctively in convulsive disorders, possibility of increase
in frequency and/ or severity of grand mal
seizures may require increased dosage of
standard anticonvulsant medication;
1~1~~
abrupt withdrawal may be associated
with temporary increase in frequency
and/ or severity of seizures. Advise
against simultaneous ingestion of alcohol
and other CNS depressants. Withdrawal
symptoms (similar to those with barbiturates and alcohol) have occurred following abrupt discontinuance (convulsions,
tremor, abdominal and muscle cramps,
vomiting and sweating). Keep addictionprone individuals under careful surveillance because of their predisposition to
habituation and dependence. In pregnancy, lactation or women of childbearing
age, weigh potential benefit against
possible hazard.
Precautions: If combined with other
psychotropics or anticonvultants, consider carefully pharmacology of agents
employed; drugs such as phenothiazines,
narcotics, barbiturates, MAO inhibitors
and other antidepressants may potentiate
its action. Usual precautions indicated in
patients severely depressed, or with latent
depression, or with suicidal tendencies.
Observe usual precautions in impaired
renal or hepatic function. Limit dosage to
smallest effective amount in elderly and
debilitated to preclude ataxia or oversedation.
Side Effects: Drowsiness, confusion,
diplopia, hypotension, changes in libido,
nausea, fatigue, depression, dysarthria,
jaundice, skin rash, ataxia, constipation,
headache, incontinence, changes in salivation, slurred speech, tremor, vertigo,
urinary retention, blurred vision. Paradoxical reactions such as acute hyperexcited states, anxiety, hallucinations,
increased muscle spasticity, insomnia,
rage, sleep disturbances, stimulation
have been reported; should these occur,
discontinue drug. Isolated reports of neutropenia, jaundice; periodic blood counts
and liver function tests advisable during
long-term therapy.

When, for example, despite counseling,
tension and anxiety continue to produce
distressing somatic symptoms

. Promnt action
is a gooll reason to
considerValium

®

Roche Laboratories
Division of Hoffmann- La Roche Inc
Nutley. N.J. 07110

(diazepam)

2-mg, 5-mg, 10-mg tablets

